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ABBREVIATIONS 
 
Acm    acetamidomethyl  
AW     azatryptophan  
BAL    backbone amide linker 
Boc    t-butoxycarbonyl 
BSA    bovine serum albumin 
c-Abl     Abelson nonreceptor protein tyrosine kinase 
CD    circular dicroism 
ctpr3    Consensus Tetratrico Peptide Repeat protein 3 gene 
CTPR3    Consensus Tetratrico Peptide Repeat protein 3 
Dab    dabcyl 
Dansyl   5-(dimethylamino)-naphtalene-sulfonamide 
DBU    1,8-diazabicyclo[5.4.0]undec-7-ene 
Dbz    diaminobenzoic acid 
DCM    dichloromethane 
DIPEA   N,N-diisopropylethylamine 
DMAP   4-Dimethylaminopyridine 
DMF    dimethylformamide 
DMSO   dimethylsulfoxide 
DNA    deoxyribonucleic acid 
dNTP    deoxy-nucleotide tri-phosphate 
ε    extinction coefficient 
E     FRET efficiency 
E. coli  Escherichia coli 
EDT    ethandithiol 
EDTA    ethylene-diamino-tetraacetic acid  
EPL    Expressed Protein Ligation 
ESI    electron spray ionization source  
FCS     Fluorescence Correlation Spectroscopy 
Fmoc    fluorenylmethyloxycarbonyl chloride 
FP    Fluorescence Polarization 
FPLC    Fast Protein Liquid Chromatography  
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FRET    Förster Resonance Energy Transfer 
GdnHCl   guanidinium hydrochloride  
GFP    Green Fluorescent Protein 
Gla    γ-carboxy-glutamic acid 
GPI    glycosylphosphatidylinositol  
HAT    histone acetyltransferase 
HOBt    Hydroxybenzotriazole 
HBTU O-Benzotriazole-N,N,N‟,N‟-tetramethyl-uronium-
hexafluoro-phosphate 
HF    fluorhydric acid 
HPLC    High Performance Liquid Chromatography  
Hsp    heat shock protein 
H2B    Histone H2B 
H3    Histone H3 
IntN    N-terminal intein domain 
IntC    C-terminal intein domain 
IPTG    isopropylbeta-D-thiogalactopyranoside 
KCL    Kinetically Controlled Ligation 
LB    Luria-Bertani Broth 
LC-MS   Liquid Chromatography Mass Spectrometry 
Mca    Methoxycoumarin 
MetAPs    methionyl aminopeptidases  
MESNA   2-mercapto-ethane sulfonate sodium 
MPAA   p-mercaptophenylacetic acid 
Mth RIR1 Methanobacterium thermo-autotrophicum ribonucleoside 
diphosphate reductase 
Mw    Molecular Weight 
Mxe GyrA   Mycobacterium xenopi DNA gyrase A 
NCL    Native Chemical Ligation  
NMP    N-methyl-2-pyrrolidone 
NMR    Nuclear Magnetic Resonance  
Npu DnaE    Nostoc punctiforme DnaE 
OD     Optical Density  
PCR    Polymerase Chain Reaction 
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PDA    photo diode array 
pI     isoelectric point 
PMSF    protease inhibitor phenylmethanesulfonyl-fluoride 
PPII    polyproline II 
PTMs    post-translational modifications 
PTS    Protein Trans-Splicing 
PVDF    polyvinylidene difluoride  
R    distance between fluorophores 
R0    Förster radius  
RabGGTase   Rab geranylgeranyl transferase 
REP    RabGGTase escort protein 
RNA    ribonucleic acid 
Sce VMA   Saccharomyces cerevisiae vacuolar ATPase subunit  
SDS-PAGE   sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SH    Src homology domain  
SPPL    Solid-Phase Expressed Protein Ligation 
SPPS    Solid-Phase Peptide Synthesis 
Ssp DnaB   Synechocystis sp. PCC6803 DnaB helicase 
STAT    signal transducer and activator of transcription  
SUMO   Small Ubiquitin-like Modifier 
TAE    Tris acetate EDTA 
TβR-I     transforming growth factor β receptor  
t-BuSH    tert-butyl mercaptan 
TCEP    Tris(2-carboxyethyl)phosphine 
TEV    protease from tobacco etch virus 
TFA    trifluoroacetic acid 
TGF-β   transforming growth factor β 
Thz    thiazolidine 
Tm    melting temperature 
TPR    Tetratrico Peptide Repeat 
Tris     Tris (hydroxy methyl) amino methane 
U     units 
Ub    ubiquitin 
UV    ultra violet 
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VA-044    2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride 
Vis    visible 
 
The three letters code is used for amino acids. 
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SUMMARY 
 
An ingenious stratagem useful to understand and modulate the structural and 
functional features of the proteins refers to the modification of their chemical 
structure. In this regard, the chemical synthesis of proteins appears a key tool, as it 
allows the unlimited modification of a polypeptide chain with any kind and number of 
labels. The last decade has seen the introduction of several techniques of chemical 
protein synthesis that allow the manipulation of proteins structure [Hahn, M.E. & Muir, 
T.W. 2005; Kent, S.B.H. 2009]. Among these approaches, the Native Chemical 
Ligation (NCL) appear as the most useful and advantageous strategy [Dawson, P.E. 
et al. 1994]. The method leads to the formation of a protein molecule through the 
chemoselective ligation of two peptide segments containing the former a C-terminal 
α-thioester group and the latter an N-terminal Cys residue. Each peptide segment is 
prepared by solid-phase peptide synthesis (SPPS) and thus can contain any useful 
chemical modifications, such as unnatural amino acids, post-translational 
modifications, isotopes and fluorophores. A semisynthetic version of NCL is the 
Expressed Protein Ligation (EPL), in which one or both of the peptide building blocks 
are made by recombinant DNA expression, while the actual ligation step is still a 
chemical reaction [Muir, T.W. et al. 1998; Evans T.C., et al. 1998]. This PhD thesis 
represents a practical guide to protein chemical synthesis and modification, as it 
presents and discusses a general protocol useful for the preparation of proteins site-
specifically functionalized with two molecular probes. The designed synthetic 
approach is based on the use of EPL and thus requires the splitting of the protein of 
interest in two fragments. The N-terminal protein fragment is expressed by 
recombinant means and is endowed of a C-terminal thioester group. Such fragment 
can be selectively labeled on its unique Cys residue with a probe containing a thiol-
reactive moiety. After first labeling, the thioester fragment is ligated to the C-terminal 
remaining protein portion, which is synthesized by SPPS and carries an N-terminal 
Cys residue, affording the full-length mono-labeled protein. The Cys residue involved 
in the ligation reaction is finally exploited to introduce the second probe into the 
protein, giving the doubly-functionalized full protein molecule. The effectiveness of 
the proposed semisynthetic protocol has been assessed through the preparation of a 
series of CTPR3 (Consensus Tetratrico Peptide Repeat protein 3) protein variants in 
which two fluorophores are incorporated at different, specific positions. The protocol 
enabled the preparation of four homogeneously doubly-labeled variants, defined 
CTPR3[N_C], CTPR3[1_C], CTPR3[2_C] and CTPR3[1_3], whose name suggest the 
positions in which the two fluorophores are located. The obtained fluorescent variants 
are useful for the conduction of folding studies by FRET (Förster resonance energy 
transfer). In this thesis are presented the results of a preliminary biophysical 
investigation performed on the obtained fluorescent CTPR3 variants by circular 
discroism and FRET. Such analysis opens the way to further folding studies on the 
fluorescent variants of CTPR3 by the use of modern biophysical spectroscopic 
methods, such as the single molecule approaches. 
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RIASSUNTO 
 
INTRODUZIONE 
In questo lavoro di tesi è proposto un efficiente protocollo di sintesi chimica utile per 
la produzione di proteine sito-specificamente funzionalizzate con una coppia di 
sonde molecolari.  
La sintesi chimica di proteine rappresenta una vantaggiosa alternativa ai metodi di  
espressione in organismi geneticamente ingegnerizzati, poiché offre la possibilità di 
modificare la struttura chimica di una proteina in maniera controllata e sito-specifica, 
introducendo in essa un‟ampia gamma di modifiche come isotopi stabili, amminoacidi 
non naturali, modifiche post-traduzionali e sonde fluorescenti, aprendo la strada a 
svariati studi strutturali e funzionali [Hahn, M.E. & Muir, T.W. 2005; Kent, S.B.H. 
2009]. Attualmente, le strategie di sintesi chimica di proteine sono per lo più basate 
sull‟impiego di approcci di Chemical Ligation [Schnölzer, M. & Kent, S.B.H. 1992], i 
quali permettono di sintetizzare una catena polipeptidica mediante l‟unione in 
sequenza dei segmenti peptidici che la compongono, ciascuno dei quali è prodotto 
mediante sintesi in fase solida (SPPS). In origine, gli approcci di CL comportavano la 
formazione di legami non peptidici in corrispondenza del sito di unione tra due 
peptidi, introducendo nella proteina alterazioni indesiderate dello scheletro 
polipeptidico. Successivamente, tale svantaggio è stato superato con l‟introduzione 
della Native Chemical Ligation (NCL) che al momento è la strategia di CL più 
ampiamente adoperata per la sintesi chimica di proteine [Dawson, P.E. et al. 1994]. 
Nelle reazioni di NCL, un peptide contenente un gruppo tioestere all‟estremità C-
terminale è fatto reagire con un secondo segmento peptidico contenente un residuo 
di Cys a monte, portando ad un unico prodotto polipeptidico tramite la formazione 
inizialmente di un legame tioestere, il quale è poi rapidamente e irreversibilmente 
convertito in un legame peptidico. Un‟ingegnosa estensione della NCL è la strategia 
di semisintesi proteica nota come Expressed Protein Ligation (EPL) [Muir, T.W. et al. 
1998; Evans T.C. et al. 1998]. L‟EPL è una variante delle strategie di CL in cui uno o 
più dei segmenti peptidici da unire in sequenza non è di origine sintetica bensì è 
espresso in forma ricombinante. Infatti, è possibile preparare i segmenti polipeptidici 
contenenti un gruppo tioestere al C-terminale o una cisteina all‟estremità N-terminale 
per via ricombinante mediante la loro espressione sotto forma di proteine di fusione 
con particolari proteine, le inteine. Queste ultime sono in grado di promuovere un 
processo noto come splicing proteico, attraverso cui il polipeptide fuso ad esse è 
rilasciato con un gruppo tioestere al C-terminale o con una cisteina all‟N-terminale, a 
seconda che tale polipeptide sia stato posto rispettivamente a monte o a valle 
dell‟inteina.  
Le strategie di sintesi chimica di proteine hanno trovato ampia applicazione in svariati 
campi scientifici, come quello biotecnologico, biofisico e biochimico [Muralidharan, V. 
& Muir, T.W. 2006]. In questo scenario si inquadra il presente lavoro di tesi. 
RISULTATI 
Strategia semisintetica 
La strategia semisintetica ideata, schematicamente rappresentata in Fig. 1, prevede 
la preparazione della proteina di interesse in due frammenti. Il frammento N-
terminale della proteina, contenente un unico residuo di cisteina, è espresso in E. coli 
sotto forma di proteina di fusione con l‟inteina Mxe GyrA. Dopo l‟espressione, la 
proteina chimerica è isolata dall‟estratto citosolico dell‟ospite batterico mediante 
cromatografia di affinità, sfruttando la presenza di una coda di poli-istidine al C-
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terminale del costrutto di fusione. La proteina di fusione è poi incubata con un 
eccesso di tiolo, il quale è capace di indurre lo splicing dell‟inteina con il conseguente 
rilascio del polipeptide fuso ad essa sotto forma di tioestere C-terminale. 
Successivamente, tale polipeptide tioestere è isolato dall‟inteina mediante HPLC a 
fase inversa e marcato con il primo probe della coppia in corrispondenza dell‟unico 
residuo di cisteina, sfruttando la reattività verso i tioli del gruppo maleimmide 
associato alla sonda. La rimanente porzione C-terminale della proteina, invece, è 
sintetizzata chimicamente mediante SPPS e espone un residuo di cisteina come 
amminoacido N-terminale. Tale residuo media una reazione di NCL con il polipeptide 
tioestere singolarmente marcato, portando alla formazione della proteina intera. Il 
residuo di cisteina coinvolto nella reazione di NCL può infine essere sfruttato per 
introdurre il secondo probe (Fig. 1 strategia A).  
 
 
Figura 1 Rappresentazione schematica della strategia semisintetica progettata per la preparazione di 
proteine funzionalizzate con una coppia di sonde molecolari. Strategia A) Approccio adottato qualora 
entrambe le sonde debbano essere introdotte in regioni interne della proteina. Strategia B) Approccio 
sintetico adoperato per la preparazione di varianti proteiche che espongono una delle due sonde in 
corrispondenza dell‟estremità C-terminale. 
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Una variante più semplice della strategia semisintetica presentata è invece 
necessaria per la preparazione di varianti della proteina di interesse doppiamente 
marcate recanti il secondo probe all‟estremità C-terminale. In questo caso, l‟intera 
proteina è espressa sotto forma di costrutto di fusione con l‟inteina e così dotata di un 
gruppo funzionale tioestere al C-terminale. Dopo il suo isolamento e la marcatura con 
il primo probe, la proteina è fatta reagire mediante NCL con L-Cisteina introducendo 
così il sito per la marcatura con la seconda sonda (Fig. 1 strategia B).  
L‟efficacia della strategia semisintetica ideata per la preparazione di proteine 
funzionalizzate con una coppia di sonde molecolari è stata dimostrata attraverso la 
preparazione di quattro varianti di una Tetratrico Peptide Repeat protein (TPR 
protein) marcate con sonde fluorescenti, utili per la conduzione di studi di folding 
mediante Förster Resonance Energy Transfert (FRET). 
 
Applicazione del protocollo di semisintesi: preparazione di varianti fluorescenti 
di CTPR3 
Le TPR proteins sono caratterizzate da ripetizioni in sequenza di un motivo 
strutturale elicoidale di 34 amminoacidi, le quali complessivamente si organizzano a 
formare strutture estese e regolari. Le proteine appartenenti a questa classe sono 
coinvolte in svariati processi biologici, quali la regolazione del ciclo cellulare, il 
controllo trascrizionale, il trasporto a livello mitocondriale e perossisomale, la 
neurogenesi ed il folding proteico. Il loro compito consiste generalmente nel mediare 
interazioni proteina-proteina, esponendo ampie superfici che fungono da scaffold per 
l‟assemblaggio di complessi macchinari biologici [Main, E.R.G. et al. 2003]. 
Attraverso un‟analisi statistica delle sequenze amminoacidiche di domini TPR 
contenuti in proteine naturali, il gruppo di ricerca diretto dalla Prof.ssa L. Regan 
(Department of Molecular Biophysics & Biochemistry, Yale University) ha identificato 
una sequenza consenso del motivo TPR. Il design di un motivo TPR “ideale”, il quale 
è stato adoperato come unità di base per costruire nuove proteine TPR contenenti un 
numero variabile di ripetizioni (definite con la sigla CTPRn, Consensus TPR numero 
di ripetizioni), costituisce un valido strumento per lo studio di questa particolare 
classe di repeat proteins [Kajander, T. et al. 2006]. Numerose analisi condotte 
mediante CD ed NMR sulle proteine CTPR suggeriscono che il processo di unfolding 
di tali proteine ripetute non segue il classico modello a due stati, caratterizzato da 
conformazioni completamente destrutturate o completamente strutturate, ma si 
adatta piuttosto al cosiddetto modello di Ising [Kajander et al. 2005; Cortajarena, A.L. 
et al. 2008; Javadi, Y. & Main, E.R.G. 2009]. Tale modello prescrive un processo di 
unfolding gerarchico, in cui le eliche più esterne delle proteine CTPR si destrutturano 
prima di quelle più interne, cosicché globalmente il processo di denaturazione 
proceda dalle estremità N- e C-terminale verso la regione centrale della proteina, 
attraversando quindi un‟ampia popolazione di stati parzialmente strutturati.  
Al fine di ottenere ulteriori informazioni sul meccanismo di folding di questa 
particolare classe di proteine, la strategia di semisintesi messa a punto per la 
preparazione di proteine doppiamente funzionalizzate con sonde molecolari discussa 
in questo lavoro di tesi è stata adoperata per la sintesi di quattro varianti della 
proteina CTPR3 (Fig. 2) sito-specificamente funzionalizzate con una coppia di 
fluorofori, utili per la conduzione di esperimenti mediante FRET.  
Le quattro varianti di CTPR3 prodotte attraverso l‟approccio semisintetico ideato 
sono state definite CTPR3[N_C], CTPR3[1_C], CTPR3[2_C] e CTPR3[1_3] e si 
distinguono per la posizione dei due fluorofori lungo la sequenza. La variante 
CTPR3[1_3] presenta entrambe i fluorofori in corrispondenza di siti interni della 
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proteina, precisamente in corrispondenza della prima e della terza ripetizione del 
motivo CTPR. Pertanto, per la sua preparazione è stata adottata la strategia 
semisintetica A di Fig. 1. Le rimanenti tre varianti CTPR3[N_C], CTPR3[1_C] e 
CTPR3[2_C], le quali presentano il secondo fluoroforo in corrispondenza 
dell‟estremità C-terminale della proteina, sono invece state preparate attraverso la 
strategia B di Fig. 1. I siti di labeling nelle quattro varianti sono stati selezionati in 
modo tale che in ciascun costrutto i fluorofori fossero posizionati a differente distanza 
tra loro e in regioni progressivamente più interne della proteina. 
 
 
Figura 2 Rappresentazione grafica della proteina CTPR3. 
 
 
Caratterizzazione spettroscopica delle varianti fluorescenti di CTPR3 
Le quattro varianti fluorescenti di CTPR3 sono state sottoposte ad una 
caratterizzazione strutturale preliminare mediante CD, da cui è risultato che le 
modifiche introdotte (mutazioni amminoacidiche e fluorofori) non compromettono 
significativamente la struttura nativa della proteina, sebbene ne riducano la stabilità 
termica. Studi di anisotropia di fluorescenza hanno inoltre dimostrato che i fluorofori 
non mediano fenomeni di aggregazione o interazione nelle proteine marcate. In 
seguito, sono stati registrati gli spettri di fluorescenza di ciascun costrutto nella forma 
nativa e chimicamente denaturata. Tale analisi ha mostrato una sensibile variazione 
dell‟efficienza di FRET tra i due fluorofori della coppia passando dalla forma nativa a 
quella denaturata di ciascuna variante di CTPR3, dimostrando che in tutti i costrutti i 
fluorofori scelti per la marcatura (ATTO 488 e ATTO 647N) sono sensibili alla 
variazione di distanza che si verifica in seguito ad unfolding.  
Considerando che il meccanismo di denaturazione delle proteine TPR sia di tipo 
sequenziale, procedendo dalle estremità terminali verso la regione centrale della 
proteina [Kajander et al. 2005; Main, E.R.G. et al. 2005; Cortajarena, A.L. et al. 2008; 
Hagay, T. & Levy, Y. 2008; Javadi, Y. & Main, E.R.G. 2009], abbiamo ipotizzato che, 
monitorando il processo di unfolding in ciascuna variante di CTPR3 mediante CD e 
FRET, si sarebbero ottenuti risultati differenti per ciascun costrutto doppiamente 
marcato. Infatti, mentre la spettroscopia CD permette di seguire il processo di 
unfolding di una proteina nel suo complesso, perché osserva variazioni del contenuto 
totale di struttura secondaria, al contrario la FRET è in grado di seguire il processo di 
unfolding della regione compresa tra i due fluorofori ed è dunque sensibile ad eventi 
di destrutturazione locale. Per verificare tale ipotesi, le quattro varianti doppiamente 
marcate sono state sottoposte ad esperimenti di denaturazione chimica condotti 
monitorando il processo unfolding sia mediante CD che FRET. Per i costrutti 
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CTPR3[1_3] e CTPR3[2_C] sono stati ottenuti risultati in accordo con il meccanismo 
di unfolding predetto per tali proteine. Invece, per le varianti CTPR3[N_C] e 
CTPR3[1_C] gli studi hanno portato ad osservazioni non in accordo con un 
meccanismo di unfolding sequenziale.  
 
CONCLUSIONI 
In conclusione, la strategia di semisintesi proteica progettata fornisce un protocollo di 
carattere generale per la funzionalizzazione multipla e sito-specifica di proteine. In 
questo lavoro di tesi la strategia ideata è stata impiegata per applicazioni biofisiche, 
attraverso la preparazione di quattro varianti della proteina CTPR3 marcate con due 
fluorofori utili per la conduzione di studi di folding tramite FRET e CD. Il risultato 
intrigante di tali studi è indicativo di una deviazione da un semplice scenario in cui le 
transizioni FRET sono funzione esclusivamente della perdita di struttura elicoidale. 
Tali studi inoltre pongono le basi per la conduzione di più approfondite analisi 
mediante tecniche all‟avanguardia, come la single molecule-FRET, volte a chiarire i 
dettagli ancora insoluti delle dinamiche di folding delle proteine TPR ed in generale di 
tutte le repeat proteins. 
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INTRODUCTION 
 
The need for protein modification strategies 
Providing a complete understanding of proteins structure and function has emerged 
as one of the great challenges in biochemistry in the post-genomics era. In the 
analysis of structure-activity relationship, the ability to manipulate the chemical 
structure of proteins appears as an ingenious stratagem to understand the basis of 
their function and structure. For the past thirty years, DNA recombinant techniques 
have been widely employed to systematically vary the amino acid sequence of a 
polypeptide in order to correlate the observed changes in the properties of the mutant 
protein with the change in the amino acid sequence. This approach, named “protein 
engineering”, has provided much useful insight into how the structure of a protein 
gives rise to its functional properties [Wells, J.A. & Estell, D.A. 1998]. The power of 
this method includes its applicability both in vitro and in vivo. However, from a 
chemist‟s point of view the molecular biology approach is subject to severe 
limitations: only the twenty genetically encoded amino acids can be introduced or 
substituted into a protein molecule and site-specific incorporation of post-translational 
modifications or molecular probes are both technically difficult and impossible to 
control precisely. Great efforts have been made to overcome these limitations, for 
instance by the use of cell-free translational system to expand the repertoire of 
ribosomal synthesis to include non-canonical amino acids as building blocks [Mendel, 
D. et al. 1995; Xie, J. & Schultz, P.G. 2005], and by the use of group-modifying 
reagents which facilitate the selective tagging of proteins isolated from living cells. 
These sophisticated approaches are original tools, but so far had only limited impact 
because relative subtle modifications are often not possible, such as replacement of 
single atom in a protein with an isotope thereof, or another atom. In addition, it is 
generally not possible to incorporate multiple, different molecular probes into discrete 
sites or regions of a protein using standard labeling procedures. These and other 
restrictions continued to fuel the development of new approaches for protein 
modifications [Kent, S.B.H. 2009]. 
 
Chemical synthesis of protein  
Great innovations in the field of proteins modification were expected to come from the 
chemical synthesis. The use of synthetic chemistry promises the unlimited variation 
of the covalent structure of a polypeptide chain, enabling to effect, at-will, any desired 
change in the protein molecule. Chemistry ensures the ability to systematically tune 
the properties of a protein molecule in a completely general fashion. Chemical 
synthesis also allows the labeling of a protein without limitations with respect to the 
type and number of labels, yet with the atom-by-atom precision that is essential, for 
instance, to the modern biophysical methods. For example, chemical synthesis is 
critical for realizing the full potential of single molecule and fluorescence studies 
[Kent, S.B.H., 2009]. The last decade, in particular, has seen the introduction of 
several techniques of chemical protein synthesis that allow the covalent structure of 
proteins to be manipulated with an unprecedented level of control [Hahn, M.E. & 
Muir, T.W., 2005]. 
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Classical organic synthesis in solution 
The quest to make enzymes and other protein molecules by chemical synthesis was 
one of the major challenges for organic chemistry in the twentieth century. The desire 
to achieve this goal led to the development of a vast array of synthetic peptide 
chemistry methods which culminated in the synthesis of a number of proteins, such 
as human insulin protein (51 amino acids) and a series of chemical insulin analogues 
[Sieber, P. et al. 1978], the enzyme ribonuclease A (124 amino acids) [Yajima, H. & 
Fujii, N. 1981] and a consensus lysozyme enzyme molecule (129 amino acids) 
[Kenner, G. W. 1977]. The protein syntheses mentioned above were carried out in 
solution and involved the preparation of short fully-protected peptide segments and 
their subsequent condensation in organic solvents (Fig. 1). 
 
Figure 1 Protein synthesis in solution phase. Peptide segment building blocks are reacted in a fully 
convergent strategy; all non-reacting functional groups in both peptide segments are masked by 
reversible protecting groups. In the final step, all the protecting groups are removed to give the full-
length polypeptide product [Kent, S.B.H. et al. 2009]. 
This classical solution approach to the chemical synthesis of polypeptide chains 
suffered from a number of shortcomings, including laborious and technically 
demanding preparation of the protected segments, lack of chiral homogeneity in 
peptide bond formation, inability to purify and characterize fully-protected peptides 
due to their low solubility [Kent, S.B.H., 1988]. Moreover, the sophisticated chemistry 
used required an exceptionally high level of skill because syntheses were arduous, 
requiring teams of expert chemists to carry out them effectively. Although a number 
of proteins were successfully synthesized by classical methods in solution, known as 
convergent synthesis, the limitations encountered using maximally protected peptide 
segments were never overcome, so that this sophisticated synthesis was abandoned. 
Solid phase peptide synthesis 
In 1963 Merrifield introduced a novel synthetic technique that greatly facilitated the 
chemical synthesis of peptides, the stepwise solid-phase peptide synthesis (SPPS). 
In SPPS, the C-terminal amino acid residue of a target peptide sequence, with side-
chain properly protected, is covalently attached to an insoluble polymeric support; for 
the introduction of the subsequent amino acid residue, the N(α)-protecting group (a t-
butoxycarbonyl –Boc- or 9-fluorenylmethoxycarbonyl –Fmoc- group) of the resin-
bound first amino acid is removed and the resin is purified by filtration and washing; 
then, the next amino acid with the N(α)- and side chain group protected is added in a 
carboxyl-activated form; after formation of the new peptide bond, excess of activated 
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amino acid and reaction by-products are removed by filtration and washing. These 
steps are sequentially repeated until the target resin-bound protected peptide chain is 
completely assembled. In the final step, all side-chain protecting groups are removed 
and simultaneously the covalent link to the resin is cleaved to release the fully-
unprotected crude peptide product (Fig. 2).  
 
Figure 2 Solid phase peptide synthesis. The fully-protected peptide chain is built up in stepwise 
fashion from the C-terminal amino acid, which is covalently attached to an insoluble polymer support. 
In the final step, all the protecting groups are removed and the covalent link to the polymer support is 
cleaved to give the full-length polypeptide product in solution [Kent, S.B.H. et al. 2009]. 
Facile purification by filtration and washing at each step of the synthesis enables the 
use of large excess of activated amino acids for each peptide bond forming step. 
Consequently, reactions are rapid and near-quantitative. Handling losses are 
minimized because the growing peptide chain remains bound to the insoluble support 
at all stages of the synthesis. As a result, with correctly designed and well-executed 
chemistry, crude products containing a high proportion of the desired peptide are 
obtained in high yield. The solid-phase method revolutionized the chemical synthesis 
of peptides because attachment of the growing protected peptide chain to the resin 
support overcomes the problems of the solution approaches. Despite the 
extraordinary power of SPPS in respect to the classical synthesis in solution, SPPS 
had no impact on the maximum size of polypeptides that could be made by chemical 
means because the lack of full-quantitative reactions and the presence of impurities 
in the solvents and reagents leads to the formation of resin-bound by-products at 
each step of reaction. This accumulation of co-products limits the ultimate size of 
high-purity polypeptides that can be effectively prepared by this way to chains of ~50 
amino acids in length. This corresponds to only the very smallest proteins and protein 
domains. Clearly, a more powerful approach based on novel principles was needed.  
A number of attempts were made to take advantage of the gained ability to make, 
characterize and handle unprotected peptides, such as the preparation of large 
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polypeptides from synthetic segments through transpeptidation reactions catalyzed 
by enzymes specifically engineered by molecular biology for this purpose [Chang, 
T.K., et al., 1994; Braisted A.C., et al., 1997]. The principal obstacle to general utility 
of enzymatic ligation has proven to be the limited solubility of even the unprotected 
peptide segments under the physiological conditions compatible with the enzymes 
used. So, despite enzymes such as subtiligase and sortase still remain in use today 
for notable applications in proteomics [Wildes D. & Wells J.A., 2010; Yoshihara H.A., 
2008] and biotechnology [Antos J. M. et al., 2009; Proft, T., 2009], such methods 
have not found widespread use. 
 
Chemical ligation reaction 
Chemical ligation of unprotected peptide segments 
A truly useful approach to chemical synthesis of proteins would take advantage of the 
ability to easily make unprotected peptide shorter than 50 amino acids in length and 
would consist of a practical way to stich such synthetic segments together to give 
polypeptide of any desired length, and hence the corresponding folded protein 
molecules. Based on this premise, in the early 1990s was introduced a novel concept 
that revolutionized the field of chemical synthesis of proteins, the chemoselective 
condensation of unprotected peptides [Schnölzer, M. & Kent, S.B.H., 1992]. In 
essence, in a chemoselective condensation reaction between unprotected peptides, 
two unique, mutually reactive groups are employed, one on each of the reacting 
unprotected peptides; these two reactive functionalities are designed to react with 
one another, but to not react with any of the other functional groups present in 
peptides, thus giving a single reaction polypeptide product (Fig. 3). 
 
Figure 3 Principles of chemical ligation. Two unprotected peptide segments are covalently joined by 
the chemoselective reaction of unique, mutually reactive functional groups, one on each reacting 
segments [Kent, S.B.H. 2009]. 
This novel approach, named “chemical ligation”, has proven to be simple to 
implement, highly effective and generally applicable [Muir, T.W. & Kent, S.B.H., 
1993]. Examples of the first proteins prepared by this way include HIV-1 protease 
[Schnolzer, M. & Kent, S.B.H., 1992] and the mirror image enzyme D-HIV-1 protease 
[deLisle-Milton, R. et al., 1993], the fully functional covalent heterodimer of b/HLH/Z 
transcription factor cMyc-Max [Canne, L. E. et al., 1995]. These and lots of other 
protein syntheses performed by the chemical ligation methods demonstrated that 
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proteins could be made in high yield and good purity from unprotected peptide 
building blocks and that unnatural analogs, containing for example post-translational 
modifications, molecular probes or unnatural amino acids, could be readily prepared 
to investigate new aspects of protein structure and function. 
Chemical ligation reactions yielding a non-native link 
A variety of chemistries has been used for the chemical ligation of unprotected 
peptides but they usually involved the formation of an non-peptide bond at the site of 
covalent linking between two reacting segments. However, these unnatural structures 
are often well tolerated within the context of a folded protein and numerous examples 
exist of fully active proteins prepared by chemical ligation strategies yielding a non-
native bond.  
From the mid-1980, hydrazone and oxime ligations found widespread use in 
synthesis of proteins [Gaertner, H.F. et al. 1992]. The reaction between a carbonyl 
group and an hydrazine or an aminooxy group is highly chemoselective and both 
reacting groups can be straightforwardly introduced in peptide by means of chemical 
organic synthesis. Slow reaction rate limited the application of this ligation methods, 
but the ability of anilines to act as a nucleophilic catalyst for hydrazone and oxime 
reaction, increasing reaction rate of three orders of magnitude, suggests a promising 
future for these kinds of imine ligations [Dirksen, A. & Dawson, P.E. 2008]. 
The Cu(I)-catalyzed azide-alkine [3+2] cycloaddition, better known as click-chemistry 
[Kolb, H.C. et al. 2001], is applied in peptide ligation, even if not as often as in the 
labeling of biological macromolecules [Dirksen, A. & Dawson, P.E., 2008]. A notable 
example of head-to-tail cyclodimerization of a protected peptide on a resin was 
described by Finn and co-workers [Punna, S. et al. 2005]. The addition of the Cu(I) 
catalyst was essential for the reaction to occur. 
Another non-native ligation chemistry employs the simple nucleophilic reaction of a 
peptide-thiocarboxylate with a bromoacetyl-peptide in aqueous solution at low pH, to 
give a thioester-linked polypeptide product. The thioester moiety is a reasonable 
facsimile of a peptide bond and the product thioester containing polypeptide is stable 
in lyophilized form [Schnolzer, M. & Kent, S.B.H., 1992].  
Developed by Saxon and Bertozzi in 2000, the Staudinger ligation reaction proceeds 
through the nucleophilic attack of a phosphine on an azide to give an azaylide 
intermediate, which is subsequently trapped in an intramolecular fashion by a 
methoxycarbonyl group on one of the aryl rings of the phosphine to give an amide-
linked phosphine oxide after hydrolys. The reaction proceeds more rapidly in protic, 
polar solvents, such as water [Lin, F.L. et al. 2005] and has been successfully applied 
in cellular labeling and in a FRET-based assay for live-cell imaging [Hangauer, M.J. & 
Bertozzi, C.R. 2008].  
Several other ligation chemistries using chemoselective reaction to form a non-native 
covalent link between two unprotected peptides have been introduced and used for 
the chemical synthesis of proteins [Dawson, P.E. & Kent, S.B.H. 2000]. One notable 
achievement has been the exploration of the Diels-Alder reaction for the ligation 
unprotected peptides. The chemoselective reaction involves a C-terminal hexadienyl 
ester and an N-terminal maleimide group and proceeds in high yield under mild 
aqueous conditions [Dantas de Araújo, A. et al. 2006]. Since both functionality can be 
readily introduced on the solid-phase, the method may find broad utility with peptides 
not containing free cysteines, due to the reactivity of maleimide toward thiol groups. 
Another promising strategy is the application of [Ru]-catalyzed ring-opening cross-
metathesis to the ligation of peptides. In some examples, the conjugation of 
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hydrophobic peptides in organic solvent yielded a linkage that could be used to 
replace proline or to introduce β–turn stabilizing units [Michaelis, S. & Blechert, S. 
2007].  
Native Chemical Ligation 
In 1994 Dawson et al. introduced an ingenious extension of the chemistries used for 
the chemoselective ligation of unprotected peptides, named Native Chemical Ligation 
(NCL) [Dawson, P.E. et al. 1994]. The mechanism of NCL is shown in Fig. 4.  
 
Figure 4 Principle of native chemical ligation. Both peptide reactants are fully unprotected and the 
reaction proceeds in water at or around neutral pH. Polypeptide building blocks contain the required 
reactive groups, namely a α-Cys or α-thioester [Dawson, P.E. & Kent, S.B.H. 2000]. 
The method leads to the formation of a single polypeptide chain bearing a native 
peptide bond at the ligation site simply mixing together two peptide segments one 
containing a carboxy-terminal α-thioester group and the other an amino-terminal Cys 
residue. The reaction is performed in aqueous solution at neutral pH under 
denaturing condition and proceeds through a trans-thioesterification reaction to the 
transient formation of a thioester intermediate, as in the strategy giving thioester-
linked polypeptide product mentioned before in this section. In NCL, however, this 
thioester-linked adduct is not stable in the conditions used for the reaction and 
undergoes a spontaneous rearrangement via intramolecular S-to-N acyl shift, giving 
the desired amide-linked product. The target full-length polypeptide chain is obtained 
without any further manipulation. In the presence of exogenous thiol, added as 
catalyst, the formation of the thioester intermediated is freely reversible under the 
neutral aqueous condition used for the reaction, instead intramolecular nucleophilic 
attack forming the amide bond at the ligation site is irreversible under the same 
conditions, so that, the overall reaction is shifted towards the formation of the native 
polypeptide product [Dawson, P.E. & Kent, S.B.H. 2000]. The yield and rate of native 
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chemical ligation is strictly dependent on the nature of the thioester moiety involved 
into the reaction. Peptide α-thioalkyl-esters are commonly used because of their ease 
of preparation. These thioalky-ester are rather unreactive, so the ligation reaction is 
generally catalyzed by in situ transthioesterification with thiols additives, usually 
thiophenol/benzyl mercaptan, sodium 2-mercaptoethanesulfonate (MESNA) or p-
mercaptophenylacetic acid (MPAA) [Johnson, E.C.B. & Kent, S.B.H. 2006]. 
Furthermore, the addition of a thiol excess not only increases the reactivity by 
forming new thioesters through transthioesterification but also keeps the thiol-
functions reduced by preventing oxidation of the N-terminal Cys. The addition of 
solubilizing agents such as urea or guanidinium hydrochloride (GdnHCl) can be used 
to increase the concentration of peptide segments, resulting in higher yields. Thus, 
after ligation, a refolding step may be required to obtain a functional protein. Similarly, 
an oxidation step is needed if the protein contains native disulfides. All the 20 
proteinogenic amino acids can be placed at the C-terminus of the thioester peptide, 
in the -X-Cys- region. However, they show different compatibility and efficiency in a 
NCL reaction. In fact, Thr, Val, Ile and Pro are reported to react slowly [Hackeng, 
T.M. et al. 1999]; Asp and Glu are less favorable because of the formation of side 
products [Villain, M. et al. 2003]. An interesting feature of NCL is that ligation occurs 
at a unique N-terminal Cys residue, even if many additional internal Cys are present 
in either segment [Dawson, P.E. et al. 1994; Hackeng, T.M. et al., 1997]. No 
protecting group are necessary for any of the side-chain functional groups normally 
found in natural proteins and near-quantitative yields of the ligation product are 
obtained. Another remarkable feature of NCL is the absence of racemization in the 
coupling reaction. Detailed studies have been carried out and no racemization was 
detected in the ligation product to a limit of <1% D-amino acid content [Lu, W.Y. et al. 
1996]. All these features have meant that NCL, together with the correlated 
Expressed Protein Ligation (EPL) (see below), is nowadays the most widely used 
method for chemical protein synthesis. 
Expressed Protein Ligation 
EPL is a semisynthetic version of NCL in which one or both of the peptide building 
blocks are made by recombinant DNA expression, while the actual ligation step is still 
a chemical reaction between a thioester moiety and a Cys [Muir, T.W. et al. 1998; 
Evans T.C., et al. 1998]. EPL overcomes most of the shortcomings of precedent 
protein synthesis and modification approaches due to the truly interdisciplinarity of its 
execution which combines the strength of organic synthesis and recombinant DNA 
technology. In EPL, a recombinant C-terminal thioester segment reacts with a 
chemically synthetized or expressed Cys-segment (or vice versa) under the same 
condition of NCL. As in NCL, even if of recombinant origin, each fragments can 
include useful modifications for biotechnological or biophysical applications, such as 
synthetic labels. The advantage of this approach respect to the classical NCL is that 
the expressed part is not limited in size, expanding the access of semisynthetic 
approaches also to very large proteins.  
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Performing Native Chemical Ligation and Expressed Protein Ligation 
The great challenge of NCL and EPL refers to the ability of preparing C-terminal 
thioester or N-terminal Cys-containing polypeptides by chemical or recombinant 
means. Robust approaches are available for introducing these reactive handles into 
peptides and polypeptides.  
Production of thioester peptides 
Currently, the most effective chemical protocols for thioester peptides production are 
performed primarily by Boc-SPPS, using thioester linkers. This kind of stepwise solid-
phase peptide synthesis chemistry necessitates of trifluoroacetic acid (TFA) 
treatments for Nα-Boc deprotection and treatment with anhydrous fluorhydric acid 
(HF) for final side-chains deprotection and cleavage from solid support. Many 
laboratories do not have the facilities needed for performing HF cleavage, due both 
to the cost of the apparatus and the hazards inherent in its operation. However, the 
extremely strong acid conditions used in Boc-SPPS are not compatible with many 
peptide modifications introduced during synthesis, such as post-translational 
modifications like glycosylation. On the other hand, the preparation of peptide 
thioesters by the alternative SPPS approach, the Fmoc-chemistry, is not directly 
accessible due to the nucleophilicity of the secondary amine, the piperidine, required 
for Fmoc removal that is incompatible with the use of the thioester linkers. The 
development of methods for the production of thioester peptides by Fmoc-SPPS has 
therefore been a major challenge over the past decade. Several approaches have 
been developed to address this problem, for example the use of an optimized Fmoc 
deprotection cocktail containing 25% 1-methylpyrrolidine, 2% hexamethyleneimine, 
2% hydroxybenzotriazole (HOBt) (v/v/w) in 50:50 N-methylpyrrolidone (NMP) and 
dimethylsulfoxide (DMSO) [Li, X.Q. et al. 1998] or the use of 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) as non-nucleophilic base to remove Fmoc 
group [Clippingdale, C.J. et al. 2000]. A further possibility is the synthesis of the 
peptide on an acid-labile resin, like Cl-trityl-resin, and the cleavage of the fully-
protected peptide chain. The thioester can be obtained by the treatment of the 
protected peptide with activating reagents and thiols. After, the peptide is deprotected 
with strong acid and purified [von Eggelkraut-Gottanka, R. et al. 2003]. The Pessi 
group proposed the safety-catch system [Ingenito R. et al., 1999] which uses the thiol 
labile Kenner‟s sulfonamide linker for Fmoc-based synthesis of C-terminal peptide 
thioesters (Fig. 5A). A novel backbone amide linker (BAL) strategy has been 
developed by Barany and extended for Fmoc-SPPS of peptide thioesters [Alsina, J. 
et al. 1999]. This strategy comprises (i) start of peptide synthesis by anchoring the 
penultimate residue, with its carboxyl group orthogonally protected by a removable 
allyl ester, through the backbone nitrogen, (ii) continuation with standard protocols for 
peptide chain elongation in the C → N direction, (iii) selective orthogonal removal of 
the carboxyl allyl ester protecting group, (iv) solid-phase activation of the pendant 
carboxyl and coupling with the α-amino group of the desired thioester C-terminal 
residue, and (v), finally, cleavage/deprotection to release the free peptide product 
into solution (Fig. 5B). Another post-SPPS thioesterification reaction use C-terminal 
N-alkyl cysteine as N to S migratory device [Hojo, H. et al. 2007] (Fig. 5C). A useful 
approach for peptide thioesters production compatible with Fmoc-chemistry was 
presented by Gaertner and co-workers [Botti, P. et al. 2004]. In this strategy, Fmoc-
Cys(tButhio)-OH is coupled to amino-Rink-PEGA resin and after Fmoc removal with 
piperidine, the N-terminal amino group is reacted with KNO2 to generate a 3-tert-
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butyldisulfanyl-2-hydroxypropionamide template as a racemic mixture. The first 
amino acid of the sequence is then attached to the template via HBTU-mediated 
coupling with DMAP as catalyst. The peptide synthesis is completed by standard 
Fmoc- chemistry and the peptide Cαcarboxyester of the 3-tert-butyldisulfanyl-2-
hydroxypropionamide is obtained by acid cleavage from resin (Fig. 5D 1). This 
species could be converted into a thioester peptide through in situ O to S acyl shift 
prior or during ligation (Fig. 5D 2). Recently, a novel method for thioester peptides 
preparation was reported based on the formation of a backbone pyroglutamyl imide, 
which, after displacement by a thiol, provides the peptide thioester [Tofteng, A.P. et 
al. 2009] (Fig. 5E). Notably, Blanco-Canosa and Dawson introduced a really 
ingenious novel strategy that promises to effectively enable the use of standard 
Fmoc-chemistry solid phase synthesis for the routine production of peptide thioesters 
[Blanco-Canosa, J.B. & and Dawson, P.E. 2008]. This alternative approach is based 
on the formation, following chain elongation, of a C-terminal N-acylurea functionality 
through the use of the more stable intermediates o-aminoanilides (Fig. 5F). Starting 
with Rink-PEG-PS resin, 3-Fmoc-4-diaminobenzoic acid (Fmoc-Dbz) is coupled and 
then deprotected with piperidine. Subsequent amino acids are coupled by standard 
Fmoc-SPPS. Following chain assembly completion, with the last amino acid 
introduced as Nα-Boc-protected, the C-terminus is activated with p-
nitrophenylchloroformate followed by the addition of a base to promote intramolecular 
attack of the anilide to form the resin bound N-acyl-urea peptide. The conversion to 
acyl-urea is quantitative and the reaction leads to the formation of two isomers in a 
ratio of 4:1. However, subsequent treatment of the peptide with MPAA rapidly yields 
a single thioester product. The peptide is deprotected and cleaved from resin with 
TFA. Importantly, this mechanism leads to less than 2% of epimerization of the C-
terminal amino acid.  
 
 
Figure 5 A) Synthesis of thioester peptides through the use of Kenner safety-catch linker and Fmoc 
SPPS. 
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Figure 5 B) Preparation of unprotected peptide thioesters using Backbone Amide Linker (BAL) 
approach for Fmoc SPPS [Alsina, J. et al. 1999]. 
 
Figure 5 C) Post Fmoc-SPPS thioesterification using N-alkyl cysteine as N- to S-acyl transfer device 
[Hojo, H. et al. 2007]. 
 
Figure 5 D, 1) Preparation of peptide-C
α
oxy-(2-tert-butyldisulfanyl-1-1carboxyamide) ethyl ester 
starting from Rink Amide PEGA Resin; 2) Native Chemical Ligation through in situ O to S acyl shift 
[Botti, P. et al. 2004]. 
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Figure 5 E) Synthesis of peptide thioesters through a backbone amide activation [Tofteng, A.P. et al. 
2009]. 
 
Figure 5 F) Synthetic strategy for Fmoc-SPPS of thioester peptides through a C-terminal N-acylurea 
functionality [Blanco-Canosa, J.B. & and Dawson, P.E. 2008]. 
The question of how to prepare recombinant polypeptides carrying a C-terminal 
thioester functionality needed for EPL reactions finds a solution into a natural 
occurring process known as protein splicing. Protein splicing is a post-translational 
process in which a precursor protein undergoes self-catalyzed intramolecular 
rearrangements that result in the precise excision of an internal segment, referred to 
as an intein, and ligation of the two flanking portions, termed exteins [Muir, T.W. 
2003; Perler, F.B. 2005]. Thus, inteins can be described as analogues of self-splicing 
RNA introns. Inteins occur in organism from all three kingdoms of life as well as in 
viral proteins and are predominantly found in enzymes involved in DNA replication 
and repair [Perler, F.B. 2000]. Inteins are promiscuous with respect to the sequence 
of the two flanking exteins, so there are no specific amino acids required in either of 
the two exteins. In contrast, inteins are characterized by several conserved key 
residue required for the basic chemical steps in splicing mechanism. As shown in Fig. 
6, the first step in the protein splicing involves an N → S (or N → O) acyl shift in 
which the N-extein unit is transferred to the side chain -SH or -OH of a Cys/Ser 
residue, located at the immediate N-terminus of the intein. This rearrangement is 
thermodynamically unfavorable; however, the intein structure catalyzes this step by 
twisting the scissile amide-bond into a higher energy conformation, thereby helping to 
push the equilibrium to the (thio)ester side [Romanelli, A. et al. 2004]. In the next 
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step, the entire N-extein unit is transferred to a second Cys/Ser/Thr residue at the 
intein-C-extein boundary (or +1 position) through a trans(thio)esterification reaction. 
The resulting branched intermediate is then resolved through cyclization reaction 
involving a conserved asparagine residue at the C-terminus of the intein and assisted 
by the penultimate His residue. The intein is thus excised as a C-terminal succinimide 
derivative. In the final and concerted step, an amide bond is formed between the two 
exteins as a result of an S → N (or O → N) acyl shift [Muir, T.W. 2003].  
 
Figure 6 Mechanism of protein splicing. The process involves a series of acyl rearrangements and 
internal reactions catalyzed by the central intein protein domain. This process results in linkage of the 
two flanking polypeptides, the N- and C- exteins, via a normal peptide bond [Muir, T. W. 2003]. 
Although the biological role of protein splicing remains an open question, the process 
has been extensively exploited in the area of biotechnology and biochemistry for its 
useful application in protein semisynthesis by EPL. In fact, a number of mutant mini-
inteins containing a C-terminal Asn → Ala mutations have been designed that can 
promote only the first step of protein splicing [Xu, M.Q. et al. 1996]. Protein 
expressed as in frame N-terminal fusion partner with one of these engineered inteins 
can be cleaved by thiols in an intramolecular transthioesterification reaction. 
Importantly, C-terminal thioester proteins can be prepared by this route and used as 
building blocks in EPL (Fig. 7).  
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Figure 7 Recombinant C-terminal thioester proteins production. Mutation of the C-terminal Asn 
residue within the intein to an Ala residue blocks the final step in protein splicing. Proteins expressed 
as in frame N-terminal fusions to much mutant inteins can be cleaved by thiols to give the 
corresponding thioester protein derivatives [Muir, T. W. 2003]. 
E. coli expression vectors are commercially available that allow the production of 
fusion constructs with engineered inteins, such as Saccharomyces cerevisiae 
vacuolar ATPase subunit (Sce VMA) intein, Methanobacterium thermo-autotrophicum 
ribonucleoside diphosphate reductase (Mth RIR1) intein or the Mycobacterium xenopi 
DNA gyrase A (Mxe GyrA) intein [Telenti, A. et al., 1997; Southworth, M.W. et al. 
1999]. Mxe GyrA intein is the most widely used for this kind of application due to its 
modest size (198 amino acids), high expression level in bacterial hosts and efficiency 
to refold from inclusion bodies, its ability to cleave efficiently with a variety of thiols to 
give the corresponding thioester protein even in presence of moderate concentration 
of denaturants, detergents or organic solvents [Valiyaveetil, F.I. et al. 2002]. For the 
thiolysis of an intein fusion protein, the choice of a certain thiol depends on the 
accessibility of the catalytic pocket of the extein/intein splicing domain and on the 
properties of the target protein. In general, the thiol should be enough small to enter 
the catalytic pocket and attack the thioester bond connecting the extein and the 
intein. Besides, the newly-formed thioester should be at the same time stable to 
hydrolysis, in order to be isolated, and reactive in EPL. As yet stated, thioalkyl-esters 
are quite stable but not enough reactive. Contrariwise, thioaryl-esters are much more 
reactive but instable. Commonly, a good compromise is reached using the thiol 
MESNA, which also has the advantage of being a non-malodourous thiol, facilitating 
thioester proteins handling and purification. Similarly as in NCL, an important factor to 
consider in choosing the protein fragment to produce as thioester for EPL reaction is 
the identity of the amino acid at the ligation site, avoiding -Ile-Cys-, -Thr-Cys-, -Val-
Cys-, -Glu-Cys-, -Asp-Cys- and -Pro-Cys- junctions. A further related issue here is 
the effect of the -1 residue on the efficiency of the protein-intein thiolysis step. Each 
intein has its set of preferences at this position: for example, certain residues are 
associated with increased levels of premature cleavage in vivo (e.g. Asp), while Pro 
is associated with no cleavage at all [Muir, T.W. et al. 2003; Southworth, M.W. et al. 
1999]. 
Thanks to their self-removing nature, the use of inteins tagged with an affinity 
appendage as fusion partner also suggests a protease-free purification system that 
can be exploited for isolating recombinant proteins without need to remove any sort 
of tag by the use of specific protease. The application of the Mxe GyrA intein for 
thioester proteins production using a protease-free purification strategy will be widely 
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mentioned in the Experimental Section of this PhD thesis due to its involvement into 
the semisynthetic protocol conceived and applied to the production of doubly 
functionalized proteins. 
Production of N-terminal Cys peptide 
A critic to NCL and EPL is that they require a Cys residue at the ligation site. It is 
often stated that this is a severe limitation of these approaches, because Cys is not 
so commonly found in proteins. This criticism is misleading; while Cys may be the 
least common amino acid found in proteins, it is equally true that there are many 
thousands of Cys-rich disulfide containing proteins in nature, and that the most 
common structural motif in the human genome is the Cys-rich zinc finger domain. All 
of these Cys containing proteins are accessible targets for chemical synthesis by 
NCL or semisynthesis by EPL. For the other proteins, lots of chemistries have been 
developed in order to extend these applications to non-Cys sites [Kent, S.B.H. 2009]. 
The most useful of these was the use of catalytic desulfurization of Cys in ligation 
product, enabling the chemical ligation to be performed also at X-Ala sites. Global 
desulfurization of the Cys residue in the final polypeptide product can be achieved by 
reduction with Raney Nickel method [Pentelute, B.L. & Kent, S.B. 2007]. Alternatively, 
a selective desulfurization can be achieved by the use of the water-soluble free 
radical initiator VA-044 (2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride), 
TCEP (Tris(2-carboxyethyl) phosphine) and t-BuSH (tert-butyl mercaptan) [Wan, Q. & 
Danishefsky, S.J. 2007]. Importantly, this latter method is compatible with the 
presence of Met residues, a wide variety of functional groups, such as post-
translational modifications and biotin, and protecting groups as acetamidomethyl 
(Acm) and thiazolidine (Thz). The desulfurization approach has been generalized 
also to other β- and γ-thiol amino acids analogs, expanding the number of amino 
acids that could be obtained following desulfurization also to Val and Thr [Chen, J. et 
al. 2008; Chen, J. et al. 2010]. Also ligation at X-Met site is possible exploiting the 
latent thiol moiety of Met by the use of homocysteine; after ligation of the N-terminal 
homocysteine peptide with the C-terminal thioester moiety, S-methylation with excess 
p-nitrobenezensulfonate yields the native Met at the ligation site [Tam, J.P. & Yu, Q. 
1998]. Indeed, recently the X-Phe ligation site became accessible for native chemical 
ligation by introducing β-mercaptophenylalanine at the ligation site [Crich, D. & 
Banerjee, A. 2007]. A limit of this strategy is that desulfurization acts uniformly 
throughout all the protein, also reducing other Cys residues eventually present into 
the protein. In this regard, Dawson group very recently proposed the use of 
selenocysteine mediated chemical ligation in combination with a protocol for the 
conversion of this amino acid to alanine which preserve native Cys residues present 
in the sequence without the need for side chain protection [Metanis, N. et al. 2010]. A 
completely different kind of approach to ligation at non-Cys sites rely on the use of 
thiol-containing N(α) auxiliaries that mimic the presence of a Cys residue at the N-
terminal of the peptide and which can be selectively removed from the newly-formed 
amide bond after the ligation reaction. The use of thiol containing auxiliaries is highly 
sensitive to the nature of the amino acid at the ligation site and is currently much less 
effective than chemical ligation at Cys. An elegant example proposed was the 
photolabile auxiliary based on the o-nitrobenzyl group [Marinzi, C. et al. 2004]. The 
use of auxiliaries as well as the use of amino acids analogs is applicable only to 
chemically synthesized Cys-peptide, due to the impossibility of introducing such 
modifications during recombinant expression. NCL and EPL have also been used for 
the chemical synthesis or semisynthesis of a wide range of fully functional proteins by 
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the simple expedient of introducing a Cys residue as needed at the ligation site. Cys 
scanning mutagenesis experiments in many proteins have shown that Cys residue 
can be introduced in the majority of positions of a protein molecule without affecting 
folding or function [Kent, S.B.H. 2009].  
While the chemical production of N-terminal Cys peptide is achievable simply by 
ending SPPS with Cys, methods for generating recombinant proteins possessing 
amino-terminal Cys residue all rely on the cleavage of an appropriate precursor 
protein (Fig. 8). In the simplest scenario, a Cys is introduced next to the initiating 
methionine in the protein sequence. Endogenous methionyl aminopeptidases 
(MetAPs) remove the initial Met, thereby generating amino-terminal Cys protein. 
However, this in vivo processing event is often incomplete. Most approaches involve 
the in vitro use of exogenous proteases. In these approaches, a factor Xa recognition 
sequence is appended immediately in front of the cryptic N-terminal Cys in the 
polypeptide of interest [Erlanson, D.A. et al. 1996]. Besides, Tolbert & Wong showed 
that the protease from tobacco etch virus (TEV) can also be used to release amino-
terminal Cys proteins from suitable precursors demonstrating that TEV protease 
could accept Cys in the P1‟ of the recognition site rather than the usual Ser or Gly 
[Tolbert, T.J. & Wong, C.H. 2002]. Moreover, a N-terminal Cys protein could be 
obtained from fusion construct with Small Ubiquitin-like Modifier (SUMO) by digestion 
of the chimeric protein with a specific protease that recognizes and selectively 
hydrolyzes the fusion partner SUMO, releasing the fused protein without any 
additional amino acid, allowing to unmask an N-terminal Cys-residue [Weeks, S.D. et 
al. 2007]. Protein splicing can also be exploited to prepare amino-terminal Cys 
proteins. Inteins have been mutated so that cleavage at the C-terminal splice 
junction, between the intein and the C-extein, can be induced in a pH and 
temperature-dependent fashion. Splicing of such an intein allows the release of an 
amino-terminal Cys protein without any further treatment. The Mxe GyrA intein was 
also adapted to this other kind of application [Southworth, M.W. et al. 1999], as well 
as the Synechocystis sp. PCC6803 DnaB helicase (Ssp DnaB) intein [Mathys, S. et 
al. 1999]. A drawback of this intein-based approach is that spontaneous cleavage 
can occur, resulting in premature loss of intein and, more importantly, the loss of the 
associated affinity tag.  
 
Figure 8 Recombinant N-terminal Cys proteins production. A Cys-protein can be produced by specific 
proteolysis of recombinant protein containing a cryptic Cys residue in the C-terminal position of a 
protease cleavage site.  In one strategy, the leader can be simply a Met, which is removed in vivo by 
specific amino-peptidase (A), or it can be a short peptide recognition sequence removed in vitro by 
cleavage with heterologous protease (B). In alternative strategy, the leader sequence consists of a 
mutated intein that undergoes specific cleavage at the intein C-extein junction in response to changes 
in pH or temperature (C) [Muir, T.W. 2003].  
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Ligation of multiple peptide fragments 
When three or more peptide fragments are to be ligated sequentially for the synthesis 
or semisynthesis of larger protein, the purification of each intermediate ligation 
product by HPLC often leads to large product losses, resulting in a low overall yield. 
To solve the problem, Kent and co-workers invented the kinetically controlled ligation 
(KCL), that relies on the large reactivity difference between a peptide-α-thioarylester 
and a peptide-α-thioalkylester [Bang, D. et al. 2006]. They first applied the KCL 
approach to the synthesis of crambrin (46 amino acid). The major challenge of the 
work was to control the intrinsic dual reactivity of a bifunctional Cys-peptide-thioester, 
impeding its self-ligation. This was achieved by protecting the N-terminal Cys residue 
of thioester peptide with a Thz group. Once the first ligation reaction reached the 
completion, the N-terminal thiazolidine was converted to cysteine with methoxylamine 
at pH 4. After that, the pH was readjusted around neutrality and the next thioester 
peptide was introduced for the subsequent ligation reaction. The thiazolidine is not 
the only one way to mask a Cys. An alternative enzymatically approach involves the 
use of proteases, such as Factor Xa or TEV, to give a new N-terminal reactive Cys. 
The proteolytic cleavage of an intermediate polypeptide containing a Cys-residue 
covered by a proteolysis site allows the appearance of a new N-terminal Cys that can 
be involved in a new ligation step. 
 
Protein semisynthesis by trans-splicing 
Several inteins can be split into two pieces that individually have no activity but, when 
mixed together, they reassociate non-covalently and fold into an active self-splicing 
unit. This process is called Protein Trans-Splicing (PTS) and proceeds in the same 
way as regular protein splicing [Southworth, M.W. et al. 1998]. The two fragments of 
the intein can reconstitute even if each portion is fused to extein (Fig. 9).  
 
Figure 9 Protein trans-splicing by split inteins. Inteins can be cut into N- and C-terminal pieces, that 
individually have no activity but that when combined, associate non-covalently to give a functional 
splicing element [Muir, T.W. 2003]. 
27 
 
Thus, the result of a PTS reaction is similar to a NCL or EPL: two polypeptide chains 
linked through a native peptide bond. Protein production through PTS bears several 
potential advantages over NCL or EPL. For example, no synthesis and isolation of a 
thioester or treatments with protease are required and the reaction does not need 
thiol excess. Furthermore, the reaction proceeds efficiently also at lower 
concentrations of the two split intein fragments. However, solubility of fusion proteins 
with many split intein fragments could be observed due to the exposure of 
hydrophobic patches leading to misfolding and aggregation and requiring renaturing 
procedure [Mootz, H.D. 2009]. Split inteins are found in nature (i.e. Synechocystis 
DnaE intein) and can also be engineered from regular (or cis) inteins. Natural or 
artificially split inteins, such as Mxe GyrA and Ssp DnaB inteins, have been examined 
in laboratory to identify different possible sites of split. Interestingly, investigations on 
split sites in the Ssp DnaB intein showed that an IntN fragment of only 11 amino acids 
and its corresponding 143 amino acids IntC counterpart were capable of protein 
trans-splicing both in vivo and in vitro [Sun, W. et al. 2004; Ludwig, C. et al. 2006]. 
Similarly, Iwai and co-workers demonstrated that the IntC fragment from Nostoc 
punctiforme DnaE intein (Npu DnaE intein) could be shortened to 15 residues without 
abolishing protein trans-splicing activity [Aranko, A.S. et al. 2009]. In a screen of 
other inteins, Liu and co-workers identified a split Ssp GyrB intein with an IntC 
fragment of only 6 amino acids able to reconstitute with the 150 amino acids 
remaining N-terminal region [Appleby, J.H. et al. 2009]. The ability to obtain inteins 
with N-terminal or C-terminal fragments so short allows the preparation of this 
segments and their exteins by SPPS, that appears as an attractive and suitable way 
for the incorporation into proteins of chemical modified segments. 
 
Applications of NCL and EPL 
NCL and EPL have found widespread application in biochemical, biotechnological 
and biophysical areas, allowing the study and the characterization of many proteins 
and leading to a great number of discoveries. The following paragraphs provide an 
overview of the major applications of NCL and EPL in protein engineering, with a 
particular attention to the use of these synthetic techniques for the production of 
labeled proteins useful for biophysical studies, which is the aim of this PhD thesis. 
Introduction of fluorescent probes 
Because of their extremely high sensitivity, fluorescence spectroscopy approaches, 
such as Förster resonance energy transfer (FRET), fluorescence correlation 
spectroscopy (FCS) and fluorescence polarization (FP), are powerful biophysical 
methods for studying protein folding, function, conformational fluctuations and 
protein-protein interactions. All biophysical techniques make use of molecular probes 
that can either be naturally present within the protein or introduced through labeling 
procedures. Nature provides us with two fluorescent amino acids, tyrosine and 
tryptophan, but their utility as fluorescent probes decreases as the size of the protein 
increases. Moreover, most large proteins contain several Trp and Tyr residues, 
thereby reducing the resolution of the analysis. For many applications it is desirable 
to employ fluorescent probes placed in specific locations inside protein and 
possessing spectroscopic properties quite different from those of the two intrinsic 
fluorophores. Conventional methods for protein derivatization with fluorophores use 
the reactivity of native or engineered Cys or Lys side chains. In fact, a large number 
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of useful fluorescent probes are available as maleimide or N-hydroxy-succinimide 
derivates that react selectively with Cys thiol or Lys ε-amino group. However, this 
approach is limited by the occurrence of multiple Cys or Lys in the same protein, 
resulting in heterogeneous and incomplete labeling. Chemical ligation approaches 
appear as the most appropriate and general methods for proteins site-specific 
labeling with fluorescent probes. In EPL and NCL approaches the traditional 
bioconjugation reactions can be performed on each recombinant or synthetic building 
block which are then ligated to obtain a site-specifically labeled protein. A large 
number of fluorescent proteins have been prepared by chemical ligation [for reviews 
see Muir, T.W. 2003; David, R. et al. 2004; Schwarzer, D. & Cole, P.A. 2005; 
Muralidharan, V. & Muir, T.W. 2006]. In the majority of the examples reported the 
probe is attached to the side-chain of an amino acid within the synthetic peptide 
building block, taking advantage of the several orthogonal protection strategies 
available that allow fluorophores to be introduced site-specifically into peptide during 
SPPS. The simplest application of protein fluorescent labeling involves the monitoring 
of the intrinsic fluorescence of a single probe during the biological process under 
investigation. Indeed, quantum yields and/or Strokes shifts of several fuorophores are 
known to be sensitive to changes in the dielectric constant of their immediate 
environment. Thus, the fluorescence of such a probe changes if it is located in a 
region that undergoes a structural change in the protein, for example following the 
interaction with a ligand or the activation through post-translational modifications. In 
one of the first applications, a sequential EPL procedure was used to incorporate the 
environmentally sensitive fluorophore 5-(dimethylamino)-naphtalene-sulfonamide 
(dansyl) between the Src homology 3 (SH3) and Src homology 2 (SH2) domains of 
the Abelson nonreceptor protein tyrosine kinase (c-Abl) [Cotton, G.J. et al. 1999]. The 
fluorescence properties of semisynthetic c-Abl were found to be sensitive to changes 
in domain orientation, allowing this construct to act as a biosensor for ligand 
interaction. In another example, Iakovenko and co-workers incorporated a dansyl 
probe into a semisynthetic version of Rab7, a small GTPase [Iakovenko, A. et al. 
2000]. The fluorophore was incorporated close to a region at the C-terminus of the 
protein that is known to be post-translation prenylated by Rab geranylgeranyl 
transferase (RabGGTase). They used this fluorescent semisynthetic Rab7 protein to 
evaluate the affinity of Rab7 for RabGGTase and for the escort protein REP-1. In a 
similar approach, Muir group used in vivo amino acid replacement to incorporate the 
tryptophan analog 7-azatryptophan (7-AW) into SH3 domain of Crk protein. Ligation 
via EPL of the 7AW-labeled SH3 domain to the SH2 domain of the same protein 
generated a multidomain protein with a single domain specifically labeled. Studies of 
this labeled protein show that the biochemical and thermodynamic properties of the 
SH3 domain do not change within the context of the larger multidomain protein 
[Muralidharan, V. et al. 2004]. A different example of biophysical application of 
chemical ligation was presented by Bertozzi group, that synthesized a series of 
glycosylphosphatidylinositol (GPI)-protein analogues differing for the glycan 
component at their C-terminus. The GPI is a posttranslational modification occurring 
at the C-terminus of many eukaryotic proteins that anchors the modified proteins in 
the outer leaflet of the plasma membrane. A combination of EPL and NCL was used 
to attach these (GPI)-protein analogues to the green fluorescent protein (GFP), used 
as fluorescence probe. These modified GFPs were incorporated in lipid bilayers, and 
their mobility was analyzed using FCS. The data from these experiments suggest 
that the GPI anchor is more than a simple membrane-anchoring device; it also may 
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prevent transient interactions between the attached protein and the underlying lipid 
bilayer, thereby permitting rapid diffusion in the bilayer [Paulick, M.G. et al. 2007]. 
A useful and widely explored application of fluorescently labeled proteins refers to 
their use in FRET studies. FRET is a physical phenomenon that occurs in systems 
having two fluorophores, one serving as donor and the other as acceptor. In a FRET 
pair the emission spectra of the donor should overlap the excitation wavelength of 
the acceptor so that, upon excitation of the donor, energy can be transferred from the 
donor to the acceptor, resulting in emission at the acceptor‟s emission wavelength. 
The energy transfer occurs only if donor and acceptor are spatially displaced within a 
discrete distance. Furthermore, the efficiency of energy transfer ( ) is function of the 
distance (R) between donor and acceptor according to the equation                       
1 + (R/R0)
6]-1, where R0 is the Förster Radius, a constant depending on the kind 
of fluorophores employed. FRET is a high sensitive method that can be used to 
monitor dynamic phenomena that bring the two fluorophores spatially closer or 
farther, such as folding/unfolding processes and protein-protein interactions. Deniz et 
al. reported a NCL based methodology for the chemical synthesis of the 
chymotrypsin inhibitor 2 and its functionalization with a couple of fluorophores. 
Protein was split into two fragments, both synthesized by SPPS using Boc-chemistry. 
N-terminal fragment was labeled on its amino group with tetramethylrhodamine 
succinimide ester before cleavage from resin. The peptide was then cleaved and 
produced as thioester. Labeled thioester peptide was reacted with the second 
fragment containing an N-terminal Cys. A thiopyridil-activated disulfide was used to 
label the Cys involved in NCL. Doubly labeled protein was used in single-molecule 
FRET assays [Deniz, A.A. et al. 2000]. Cotton and Muir described a solid-phase 
expressed protein ligation (SPPL) strategy that enables large semisynthetic proteins 
to be assembled on a solid support by the controlled sequential ligation of a series of 
recombinant and synthetic polypeptide building blocks. This modular approach was 
used to label the amino and carboxyl termini of the Crk-II adapter protein with the 
FRET pair fluorescein and tetramethylrhodamine. Phosphorylation by the 
nonreceptor protein tyrosine kinase c-Abl of the dual labeled Crk-II construct resulted 
in a fluorescence change of the FRET pair [Cotton, G.J. & Muir, T.W. 2000]. In 
subsequent studies, they designed and synthesized an extremely sensitive doubly 
labeled truncated version of Crk-II that enabled real-time monitoring of c-Abl kinase 
activity and provided a rapid approach to screening potential c-Abl kinase inhibitors 
[Hofmann, R.M. et al. 2001]. At my knowledge, this is the only one example of 
protocol based on EPL described for the double labeling of a protein with 
fluorescence probes. The Ebright group used EPL-labeling and cysteine-labeling to 
introduce the fluorophores of a FRET pair into different subunits of the E. coli RNA 
polymerase holoenzyme. The researchers studied the mechanism of transcription 
initiation and RNA polymerase translocation by using doubly labeled complex 
containing promoter DNA, σ70 factor and RNA polymerase core enzyme, this latter 
prepared and labeled by EPL [Mukhopadhyay, J. et al. 2001]. The group carried out 
numerous FRET experiments on this complex and elaborated a structural model for 
the RNA polymerase holoenzyme [Mekler, V. et al. 2002]. Xie et al. described an 
approach for the identification and characterization of histone acetyltransferases 
(HATs) inhibitors using FRET and fluorescence polarization. EPL was used to label 
the HATs PCAF and p300 with Dabcyl (Dab) as FRET acceptor. Methoxycoumarin 
(Mca) was conjugated to HAT substrate analogues through SPPS to function as 
fluorescent donor. When a ligand-protein interaction occurs, the fluorescent intensity 
of the donor fluorophore Mca decreases due to FRET quenching by the acceptor 
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Dab. Meanwhile, the formation of ligand-protein complexes causes reduction of the 
molecular mobility of the donor fluorophore, resulting in increased fluorescence 
anisotropy. Thus, dual modes of fluorescence measurement, FRET and anisotropy, 
are integrated in the same assay system [Xie, N. et al. 2009]. A FRET based 
approach to observe protein oligomerization was described by Scheibner et al. 
[Scheibner, K.A. et al. 2003]. A synthetic dipeptide Cys-Lys(ε-fluorescein) (donor) or 
Cys-Lys(ε-rhodamine) (acceptor) was attached via EPL to the C-terminus of a 
recombinant protein and a mixture of the two singly-labeled proteins analogs with the 
donor or the acceptor fluorophore was analyzed for FRET potential. Three proteins 
were analyzed by this mean, the known protein dimer glutathione S-transferase, that 
showed evidence of FRET, the known protein monomer SH2 domain phosphatase-1, 
that did not display FRET and finally the previously uncharacterized serotonin N-
acetyltransferase, that displayed significant FRET, indicating its likely propensity for 
dimerization or more complex oligomerization. These results establish the potential of 
the union of EPL and FRET in the analysis of protein-protein interactions.  
Also protein trans-splicing have been widely used for site-specific protein labeling 
with fluorophores, as presented in estimable works of Mootz group [Kurpiers, T.& 
Mootz, H.D. 2008 and 2007; Ludwig, C. et al. 2006] in which they show strategies to 
append a labeled tag to N-terminal or C-terminal of a protein of interest using split 
inteins. Protein trans-splicing was also used for the introduction of a FRET pair into a 
single protein [Yang, J.Y. & Yang, W.Y. 2009]. The general applicability of this 
approach is however limited by the instability of the split protein fragments which can 
aggregate in inclusion bodies. 
Introduction of isotopic probes 
EPL, PTS and NCL are of great utility for proteins characterization by nuclear 
magnetic resonance (NMR) spectroscopy because they have allowed to extend the 
use of such biophysical technique also to large, multidomain or repeat proteins. In 
fact, a major drawback of NMR applied to macromolecules are its size limitation, 
caused by a progressive loss of resolution as the number of amino acids increases in 
a protein, and the difficulties in analyzing repeat proteins in which most of the 
chemical shifts are overlapped. The production of proteins by ligation methods 
resolves this issue by allowing selected portions of a protein to be specifically labeled 
with isotopes for NMR studies. The great advantage of this synthetic approach, 
named segmental isotopic labeling, refers to the ability to specifically label with 
isotopes only a single segment, domain or repeat of a protein, and analyze it by NMR 
spectroscopy in its native multidomain context. In a general segmental isotopic 
labeling strategy, a uniformly labeled protein fragment, usually of recombinant origin, 
is ligated to an unlabeled one. As an example, in pioneering studies Muir group used 
EPL to introduce an 15N-labeled domain within the Src-homology domain derived 
from c-Abl protein tyrosine kinase [Xu, R. et al. 1999]. In this EPL based strategy, a 
part of the protein of interest was bacterially expressed in a growth medium enriched 
with the 15N isotope. Subsequent ligation of this labeled protein portion with the 
unlabeled remaining part yielded the desired segmentally labeled full-product. 
Recently, Gierasch group used EPL to create an Hsp70 molecular chaperone where 
only one of the two constituent domains was labeled with NMR active isotopes, 
allowing visualization of the single domain in the context of the two domains full 
protein. The NMR spectrum of the segmentally labeled protein was considerably 
simplified, enabling unequivocal signals assignment and enhanced analysis of 
dynamics, as a prelude to exploring the energy landscape for allostery in the Hsp70 
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family [Clerico, E.M. et al. 2010]. An elegant approach was proposed by Zhao et al., 
that reported an efficient on-column EPL strategy for the production of human 
apolipoprotein E (apoE) triply labeled with 2H, 15N and 13C. They prepared by 
recombinant route a deuterated N-terminal domain of the protein as C-terminal 
thioester by fusion to the Mxe GyrA intein; this segment was then ligated to 15N/13C 
isotopically labeled remaining portion of the apoE, similarly produced in bacterial 
host, and containing an appositively introduced N-terminal Cys [Zhao, W. et al. 2008]. 
EPL, PTS and NCL are useful approaches even for the site-specific introduction of 
one or few stable isotopes within a protein, allowing straightforward assignment of 
resonance from the labeled amino acids. A comprehensive example, was reported by 
Romanelli et al. Using EPL, the scissile peptide bond at the N-extein-intein junction of 
Mxe GyrA intein was uniquely labeled with 13C and 15N nuclei. This allowed the 
amide 1JNC‟ coupling constant to be measured on the active intein. Based on this 
analysis, this amide appears to be unusually polarized, perhaps because of 
nonplanarity. These studies supported the "ground-state destabilization" reaction 
mechanism for the first cleavage step in protein splicing [Romanelli, A. et al. 2004]. In 
another example, a series of 13C-labeled amino acids were incorporated into the C-
terminus of the α-subunit of a heterotrimeric G protein [Anderson, L.L. et al. 2005]. 
Using EPL, 9-mer peptides containing 13C labels in Leu-348 (uniform), Gly-352 
(alpha carbon), and Phe-354 (ring) were ligated to recombinant Gα subunit lacking 
the corresponding carboxyl-terminal residues. Analysis of the 13C resonances 
indicated that the C-terminus of the Gα subunit is unstructured when the protein is 
bound to GDP, but adopts an ordered conformation upon activation. Segmental 
labeling was also carried-out by trans-splicing, as reported by Iwai group which 
described a strategy to label an internal region of a protein of interest using split 
inteins [Busche, A.E. et al. 2009]. 
Introduction of post-translational modifications: phosphorylation, glycosylation, 
lipidation, ubiquitylation 
The functional state of many proteins is regulated through post-translational 
modifications (PTMs). A full molecular understanding of how a modification affects 
protein function and structure can be achieved only through studies on the 
homogeneously modified protein. Recombinant expression of post-translational 
modified full-proteins is not trivial and often results in heterogeneous preparations. 
Similarly, methods for preparing proteins modified with PTMs by enzymatic 
treatments not always proceed with high yields, and the position of the modification 
cannot be controlled. EPL and NCL provide a solution to the problem allowing the 
preparation of appropriately modified peptides that can be ligated to give the full 
functional protein that can be biophysically and biochemically characterized. One of 
the first applications refers to the incorporation of phosphorylated residues into a 
protein. The availability of semisynthetic phosphorylated proteins allowed their high-
resolution structure to be determined by biophysical technique such as 
crystallography. Phosphorylation is a critical modification for the transmission of 
information through cellular signaling pathway. The utility of synthetic approaches for 
shedding light on the role of phosphorylation is well illustrated by the work of Muir 
group on TGF-β signaling [Muir, T.W. 2008]. A tetra-phosphorylated derivative of the 
cytoplasmic domain of type 1 transforming growth factor β receptor (TβR-I) was 
prepared by ligation of a tetra-phosphopeptide thioester to a recombinantly 
expressed fragment [Huse, M. et al. 2000]. Access to homogeneous preparation of 
hyperphosphorylated TβR-I allowed the study of molecular receptor activation. In 
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related experiments, EPL was used to study the effect of phosphorylation on protein 
Smad2 transcription factor, the natural substrate of TβR-I. Phosphorylated Smad2 
was prepared through the ligation of a synthetic bis-phosphopeptide or mono-
phosphopeptide to a recombinant C-terminal thioester protein [Wu, J.W. et al. 2001; 
Ottesen, J.J. et al. 2004]. An intriguing focus of Muir group in TGF-β signaling has 
therefore been the development of chemistries to control the activity of a post-
translational modified protein inside living system. They developed two strategies that 
allow the control of Smad2 activation with light. In one approach, EPL was used to 
chemically ligate a recombinant protein fragment of Smad2 to a synthetic segment 
bearing two phosphate moieties masked with 2-nitrophenylethyl protecting groups, 
which could be removed using UV light [Hahn, M.A. & Muir, T.W. 2004]. Biochemical 
and biological assays demonstrated that the resulting caged semisynthetic protein 
was activated upon irradiation with UV light. Subsequently, a bis-phoshorylated 
Smad2 was modified with a fluorophore and a photocleavable linker that acted as 
both a caging group and a fluorescence quenching group. UV irradiation led to the 
removal of the photolinker, with release of fluorescence, and activation of the protein 
[Hanh, M.E. et al. 2007]. This technology allows the direct imaging of a protein-
activation event and its titration. A further target of protein phosphorylation by 
chemical synthesis is the tyrosine kinase Csk, which has been the first protein 
semisynthesized by EPL [Muir, T.W. et al. 1998]. A more recent example was 
reported by Becker group [Lahiri, S. 2010]. They described an approach to selectively 
analyze the impact of phosphorylation of the signal transducer and activator of 
transcription STAT6 on STAT dimerization, DNA binding and nuclear import by 
accessing six types of semisynthetic STAT6 proteins via EPL. 
Understanding how glycosylation regulates protein function was also hampered by 
difficulties associated with the production of homogeneous samples. Indeed, the 
complex structure of oligosaccharide modifications make the production of chemically 
defined glycosylation a considerably more daunting challenge than the synthesis of 
phosphoproteins. Nonetheless, rapid progresses continue to be made on the 
chemical and enzymatic synthesis of large carbohydrates and glycopeptides 
[Grogan, M.J. et al. 2002] that can be successfully combined to EPL and NCL for the 
production of glycosylated proteins. Bertozzi group pioneered the field, being the first 
group to apply NCL and EPL to the preparation of O-linked glycoproteins. For 
example, they used EPL for the synthesis of three semisynthetic variants of the 
physiologically relevant glycoprotein GlyCAM-1 containing saccharides at 
predetermined sites [Macmillan, D. & Bertozzi, C.R. 2004]. Imperiali group have 
developed NCL based approach for the production of a N-linked chitobiose 
glycoprotein analogue of immunity protein Im7 with an Ala29Cys mutation. The 
semisynthetic approach relies on the solid-phase peptide synthesis (SPPS) of N-
terminal thioesters, in glycosylated or unglycosylated form, in combination with the 
expression of the C-terminal fragment of Im7 [Hackenberger, C.P. et al. 2005]. 
Yamamoto et al. presented the synthesis of a single glycoform of monocyte 
chemotactic protein-3 (MCP-3), a CC-chemokine that consists of 76 amino acids and 
one N-glycosylation site. A three-segments native chemical ligation strategy was 
employed using unprotected peptides and glycopeptides [Yamamoto, N. et al. 2008]. 
Lipidation represents another important class of protein modification whose role in 
targeting proteins to cellular membranes is well documented. As with phosphorylation 
and glycosylation, the preparation of homogeneously lipidated protein is problematic 
due to problems of solubility and stability of the resulting conjugate in aqueous 
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solution. Once again, EPL and NCL may provide a practical solution. A noteworthy 
application of synthetic approaches to the assembly of lipid-modified proteins for 
biophysical studies refers to the co-crystal structure of a prenylated version of the 
GTPase Ypt1 in complex with Rab GDP dissociation inhibitor [Rak, A. et al. 2003]. 
Another prominent PTM is ubiquitylation. Ubiquitin (Ub) is a higly conserved 76-
residue-long eukaryotic protein that plays essential role in cellular processes such as 
proteosomal degradation, endocytosis of membrane receptors, regulation of gene 
transcription. In the cell, Ub is enzymatically activated as C-terminal thioester and 
reacts with a Lys ε-NH2 of the target protein, generating an isopeptide bond. 
Ubiquitylation is even more challenging to perform than other PTMs due to the size of 
the modification itself (8 kDa) [Muir, T.W. 2008]. EPL and NCL are useful to the 
resolution of the problem. A recent key strategy involved the use of a photocleavable 
ligation auxiliary, which is coupled to the side-chain of a target lysine residue in a 
synthetic peptide. The auxiliary functions as a N-terminal Cys surrogate and reacts in 
an EPL reaction with the recombinant Ub thioester. Following the ligation, the 
auxiliary is removed by photolysis [Chatterjee, C. et al. 2007]. This approach has 
been used for the production of ubiquitylated histone H2B. The target protein was 
assembled from three pieces, two recombinant C-terminal thioester and one 
synthetic peptide, and employed two orthogonal EPL reaction. The first ligation 
reaction involved the photolytic ligation auxiliary described above, whereas the 
second ligation was carried out standardly and involved a desulfurization step to 
convert the Cys residue at the ligation site back into the native Ala of H2B [McGinty, 
R.K. et al. 2008; Muir, T.W 2008]. Because histones are proteins heavily post-
translationally modified with a wide variety of possible modifications regulating 
structure and function of chromatin in transcription, DNA replication, repair and 
condensation, they have been a common target of chemical synthesis and 
semisynthesis. In a pioneering study, Peterson group prepared by NCL an H3 variant 
modified with a phosphoserine at position 10 [Shogren-Knaak, M.A. et al. 2003]. By 
similar methods, a site-specifically Lys16-acetylated H4 derivative was prepared 
[Shogren-Knaak, M. et al. 2006].  
Introduction of unnatural amino acids 
NCL and EPL allow the introduction into a protein of an almost unlimited range of 
unnatural amino acids at any specific site. Multiple substitutions can also be 
incorporated into a protein molecule, enabling combination of number, type and 
position of noncoded amino acids. Noncoded amino acids are frequently found in 
native proteins in vivo. These arise from specific post-translational enzymatic 
modification of coded amino acid residues. One common modification of this type is 
γ-carboxy-glutamic acid (Gla), found for example in the eponymous Gla domains of 
plasma proteins. A polypeptide construct containing the first three domains of human 
plasma protein S, including a Gla rich module with 11 Gla residues, has been 
synthetized from three segments by NCL [Hackeng, T.M. et al. 2000]. Cole group 
used EPL to incorporate a tyrosine phosphonate, a nonhydrolyzable stable analog of 
phosphotyrosine, at the C-terminal of SHP-2 phosphatase, allowing to study the 
effect of tyrosine phosphorylation on structure and function of the protein [Lu, W. et 
al. 2001]. In other examples from the same group, a series of unnatural tyrosine 
analogues, such as fluorinated tyrosines, aminophenylalanine, methyltyrosines and 
ATP-linked phenylalanine were incorporated through EPL into the protein tyrosine 
kinase Src in place of the natural tail tyrosine residue [Wang, D. & Cole, P.A. 2001; 
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Shen, K. & Cole P.A., 2003]. In further experiment on Src kinase, Virdee et al. 
performed the semisynthesis of Src homology 2 (SH2) ligand binding domain from 
three fragments by NCL. Using this strategy, they replaced a key lysine residue with 
lysyl derivatives possessing progressively shorter aliphatic side chains. Biophysical 
characterization of these SH2 domain analogs allowed a systematic dissection of the 
side chain length contribution from a lysine residue to ligand binding and showed that 
the specificity of the SH2 domain of the Src kinase can be altered by incorporation of 
such lysyl derivatives [Virdee, S. et al. 2010]. Unnatural amino acids can also be 
introduced at the ligation site within semisynthetic proteins by changing the chemical 
apparatus used in NCL and EPL. In this regard, it has been demonstrated that N-
terminal homocysteine and selenocysteine peptide can be used in ligation reactions 
[Tam, J.P. & Yu, Q. 1998; Hondal, R.J. et al. 2001], with useful applications 
respectively in peptide synthesis and protein structural studies by crystallography. 
The introduction of unnatural amino acids can also be used to modify the backbone 
structure of a protein. For example, Raines group reported the use of EPL to alter the 
ribonuclease A (RNase A) overall geometry, replacing an entire element of 
secondary structure, a β-turn, with the reverse-turn mimetic R-nipecotic acid-S-
nipecotic acid [Arnold, U. et al. 2002]. The RNase analog showed the same catalytic 
activity of the wild-type protein and an increased thermal stability.  
The study of the structure and function of ion channels has greatly benefited from 
protein synthesis by NCL and EPL. Synthetic protocols have been developed to 
generate folded channels and channel analogs containing unnatural amino acids. 
Notably, Muir and co-workers developed an EPL-based protocol to generate folded 
tetrameric potassium channel KcsA. This semisynthetic method was adopted to 
produce a KcsA analog with Gly77 replaced by D-Ala that resulted in channel 
functional loss, confirming the contribution of Gly77 in the selectivity filter 
[Valiyaveetil, F.I. et al. 2004]. Recently, Valiyaveetil described the semisynthesis by 
EPL of NaK, a bacterial non-selective cation channel. In the semisynthesis, the NaK 
polypeptide was assembled from a recombinant thioester peptide and a chemically 
synthesized peptide. Semisynthesis was also used to substitute Asp66 in the 
selectivity filter region of the NaK channel with the unnatural amino acids homoserine 
and cysteine sulfonic acid. Functional analysis of these mutants suggested that the 
presence of a negatively charged residue in the proximity of the ion binding sites is 
necessary for optimal flux of ions through the NaK channel [Linn, K.M. et al. 2010]. 
Production of insoluble or cytotoxic proteins 
The recombinant expression of some proteins, like membrane proteins, have proven 
to be very hard due to the high propensity of the overexpressed protein to aggregate 
as inclusion bodies in the cytosol. As yet affirmed, integral membrane proteins can be 
successfully synthesized in large amounts by chemical ligation approaches 
[Valiyaveetil, F.I. et al. 2002; Linn, K.M. et al. 2010]. Another problem is that, in some 
cases, the expression of a desired protein in bacteria can cause cytotoxic side-effects 
because the target protein competes with cellular components of the host. By using 
EPL or NCL techniques this can be avoided through modular synthesis of the target 
protein. After ligation and refolding, the native conformation and biological 
functionality of a cytotoxic protein can be recovered [David, R. et al. 2004]. The 
potential cytotoxic RNase A was expressed by this method [Evans, T.C. Jr. et al. 
1998]. One part of the protein was expressed as intein fusion construct and obtained 
as C-terminal thioester after thiolysis. The C-terminal truncated RNase A was then 
joined with a fragment synthesized by SPPS that contained a naturally occurring Cys 
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residue at N-terminus. Ligation of both enzymatic inactive fragments led to the full-
length protein, which reconstituted its activity after several renaturation steps. Intein 
based trans-splicing system also seem to be adequate workhorse for applications in 
cytotoxic proteins production. 
Backbone cyclization 
Backbone cyclization improves the stability and activity of peptides and proteins and 
reduces their conformational flexibility. Many pharmaceutically important natural 
products, including several antibiotics and immunosuppressants, are based on cyclic 
peptides. Thus, the ability to synthesize backbone cyclic peptides has important 
implications for drug development. Head-to-tail cyclized protein can be prepared 
using an intramolecular version of NCL or EPL, through the formation of a new 
peptide bond between N- and C-termini. To this purpose, the precursor polypeptide 
have to contain both an N-terminal Cys and a C-terminal thioester. Such a 
polypeptide can be prepared by recombinant means, flanking the protein of interest 
with two inteins. The N-terminal modified intein (for example Ssp DnaB intein) can be 
cleaved by temperature or pH, releasing the α-Cys, whereas the C-terminal intein (for 
example Mxe GyrA intein) is cleaved by thiols, leading to the formation of the 
complementary reactive group α-thioester. This “two intein system” allows the 
preparation of N-terminal Cys and C-terminal thioester containing polypeptides that 
can react to give cyclic peptides or multimers. In another approach, circularization 
occurs after unmasking of the N-terminal Cys of a thioester polypeptide, for example 
by proteolysis. The resulting Cys attacks the thioester resulting in the backbone 
circularization through a ligation reaction. Several approaches use intramolecular 
trans-splicing for the generation of cyclic backbone in vivo and in vitro. In this case, 
the split intein is not coupled to a cleaved protein or two proteins which should 
knotted, but the two split intein parts flank the N-terminal and C-terminal region of the 
same polypeptide chain in a rearranged order (IntC–target protein–IntN). Intein 
reconstitution and self-cleavage result in the releasing of a cyclic protein. In a recent 
application of protein cyclization, a mutant of green fluorescent protein (GFP) was 
cyclized in vitro and in vivo by the use of a naturally split intein Ssp DnaE. The 
circular mutant GFP was more thermostable than the linear form, significantly more 
resistant to proteolysis of exopeptidase and also displayed increased relative 
fluorescence intensity [Zhao, Z. et al. 2010].  
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Tetratrico Peptide Repeat (TPR) proteins 
The Tetratrico Peptide Repeat (TPR) is a structural motif widely diffused in proteins 
from all kingdoms of life that mediates protein–protein interactions in a multitude of 
biological processes, such as cell cycle regulation, transcriptional control, 
mitochondrial and peroxisomal protein transport, neurogenesis, protein folding and 
cancer. As denoted by its name, the basic TPR motif consists of 34 amino acids 
which assemble into a characteristic helix-turn-helix structure. TPR domains contain 
multiple copies of this α-helical motif arrayed in tandem to form an elongated 
structure in which each motif stacks on the top of the next one, thereby forming a 
regular, right-handed superhelical arrangement that can be imagined as a spiral 
staircase [D‟Andrea, L.D. & Regan, L. 2003]. In theory, there should be no limit to the 
number of repeats possible within a TPR domain. However, modules with three 
tandem TPR repeats are by far the most common in nature, and presumably 
represent the minimal functional binding unit [Main, E.R.G. et al. 2003]. As a 
consequence of their elongated and repetitive architecture, TPR proteins, as well as 
other repeat proteins, have shape, structure and properties very different from those 
of typical globular proteins [Hagay, T. & Levy, Y. 2008]. This class of proteins is 
dominated by short-range and regularized interactions between amino acids 
relatively close together in the sequence, whereas globular proteins exhibit complex 
topologies that frequently result in numerous long-range interactions [Main, E.R.G. et 
al. 2005]. The innovative modular structure, the high stability and the ability to bind to 
different ligands using a common scaffold make TPR proteins an intriguing and 
interesting research target.  
Through a statistical analysis of TPR-containing protein sequences, Regan and co-
workers designed a TPR consensus sequence by identifying the amino acid with the 
highest propensity for each of the 34 positions within the motif [Main, E.R.G. et al. 
2003; D‟Andrea, L.D. & Regan, L. 2003]. To this purpose, a non-redundant proteins 
database was scanned, all TPR sequences were retrieved and the amino acid 
distribution for each of the 34 TPR positions was determined (Fig. 10 and 11). 
Although the TPR motif shows a highly degenerate sequence, with no positions 
invariant, there is a consistent pattern of small and large hydrophobic residues that 
are essential for the structural integrity of the TPR fold. These residues, which are 
boxed in yellow in Fig. 10, present the highest global propensity values, and can be 
thought of as the TPR motif‟s “signature residues” because they form many of the 
fundamental inter- and intra-repeat packing interactions. As shown in Fig. 11, the 
sequence Gly-Asn-Ser and an additional “solvating” helix were respectively added at 
the N-and C-terminus of the TPR motif to stabilize the sequence [Main, E.R.G. et al. 
2003]. Consensus TPR modules can be arrayed in tandem to create new optimized 
TPR proteins containing a different number of repeats (CTPRn) that can be used as 
a general tool to study repeat proteins, allowing a better understanding of the 
features of this class of proteins (Fig. 12). 
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Figure 10 Histogram showing the global propensity of the three most prevalent amino acids at each of 
the 34 positions of the TPR motif. Values were obtained from a statistical analysis with the PFAM 
database. The column corresponding to the amino acid with highest global propensity is shaded pale 
yellow; the second highest, pink; the third highest, blue. The sequence corresponding to the amino 
acids with the highest global propensity at each position is shown along the top of the figure. The 
highly conserved “TPR signature residues” and their numbers are boxed in yellow [Main, E.R.G. et al. 
2003]. 
 
 
Figure 11 Schematic illustration of the designed CTPR protein. Shown are the N-cap (green), TPR 
motif (helix A, red; helix B, blue), link regions (black), and solvating helix sequence (yellow). The 
sequence of the N-cap region and the solvating helix are shown above the figure. The solvating helix 
sequence is derived from helix A, in which residues exposed to the solvent were mutated to increase 
solubility (W4K, Y5Q, Y11K and Y12Q, where the number refers to TPR position). The sequence 
corresponding to the amino acids with the highest global propensity at each position is shown below 
the figure. The highly conserved „TPR signature residues‟ are shown in blue. Mutations reported to be 
inserted in the TPR prototype sequence are shown in red. The final sequence of the designed 
consensus variant was GNS (AEAWYNLGNAYYKQGDYDEAIEYYQKALELDPNN)n 
AEAKQNLGNAKQKQG [Main, E.R.G. et al. 2003]. 
 
 
Figure 12 Ribbon representation of A) CTPR2, PDB ID 1NA3 and B) CTPR3, PDB ID 1NA0 crystal 
structures. The two helices of each TPR motif are named as helix A and B and identified with the 
number of the repeat. In the picture the helices of CTPR2 and CTPR3 are represented in different 
colors [Main, E.R.G. et al. 2003]. 
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Synthetic genes encoding the novel CTPR proteins with an increasing number of 
repeats were created, and the CTPR proteins overexpressed and purified from E.coli. 
All the variants produced adopt the typical TPR fold and were shown to be stable, 
monomeric and highly soluble [Main, E.R.G. et al. 2003]. The design of idealized 
proteins that can adopt a TPR typical fold allowed to better understand the features 
of this class of proteins. Using these ideal TPR proteins, Regan group studied the 
folding mechanism of repeat proteins and demonstrated [Kajander, T. et al. 2005; 
Cortajarena, A.L. et al. 2008] that this class of proteins does not conform the typical 
two-state folding mechanism, generally assumed for globular proteins and consisting 
of only fully folded or unfolded species. Rather, TPR folding can be quantitatively 
described by the classical one-dimensional Ising model [Zimm, B.H. & Bragg, J.K. 
1953], which prescribes the existence of a wide population of partially folded 
configurations with significant statistical weight. The Ising model predicts a 
hierarchical unfolding process in which each helix behaves as a single folding unit 
and the outermost helices show a significantly higher probability of being unfolded 
than the inner helices. Kajander and coworkers [Kajander, T. et al. 2005] observed 
that, as the number of the repeats increased, the folding/unfolding transition midpoint 
occurred at increased temperature or GdnHCl concentrations and, equally, also the 
slope of the unfolding curve increased (Fig. 13). These observations are expected for 
proteins that fold following the Ising model rather than a two-state mechanism. 
Hydrogen/deuterium exchange (HX) studies lend support to this picture. Regan and 
coworkers measured the native state hydrogen exchange for the consensus proteins 
CTPR2 and 3, and observed that the distribution of protection factors along the 
polypeptide backbone was consistent with the “end frying” predicted by the Ising 
model. These HX data demonstrated that helices closer to the end unfold first and, 
globally, the protein unfolds from both N and C termini toward the center [Main, 
E.R.G. et al. 2005; Cortajarena, A.L. et al. 2008]. Javadi and Main also supported this 
theory exploring the energy landscape of a series of designed CTPR proteins. They 
investigated the kinetic folding cooperativity and folding energy landscapes on 
increasing repeat protein length by comparing the folding kinetics of a series of 
designed CTPR proteins. The results showed that as a repeat number increases the 
landscape became more complex, with intermediates increasingly populated [Javadi, 
Y. & Main, E.R.G. 2009]. A very interesting feature of CTPR proteins was described 
in Cortajarena et al. 2008. They used FCS to analyze the hydrodynamic radius (Rh) 
of a set of CTPR proteins in the denatured state. The results revealed that, in 
presence of GdnHCl, Rh values observed for repeat proteins containing 2-20 tandem 
copies of TPR motif strongly deviated from those predicted for random coil structures. 
Rh values observed indicated a significantly more compact structure of the unfolded 
state of CTPR proteins. The origin of this unexpected behavior can be ascribed to the 
presence of an extensive nonnative polyproline II (PPII) helical structure in the 
denatured proteins, that was detected by CD spectroscopy. In fact, it is established 
that PPII helix have a distinctive CD spectrum, with a maximum at 229 nm [Woody, 
R.W. 1992], as observed in the spectra of CTPR proteins at different concentrations 
of GdnHCl (Fig. 14). In the same work, Cortajarena and coworkers identified the 
segment of the repeat proteins which assumes a PPII helical conformation. The 
segment overlaps the last helix of a motif (helix B) and the first helix of the next motif 
(helix A). Moreover, to better understand the effect of PPII structure on the 
dimensions of the denatured CTPR proteins, they performed simulation using simple 
lattice model of polymers. They showed that chains with a regularly-ordered 
sequence of short and long links (the latter representing PPII segments) may attain a 
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more compact structure than that predicted for standard random structure. The 
incorporation of interactions between PPII segments in the model leads further 
compaction of the chains, with size scaling similar to that observed in the experiment. 
Concluding, PPII structure induces significant compaction of denatured proteins, with 
high effects on the dimension of the denatured protein state. The formation of 
nonnative structure in denatured state may have implications for the folding 
mechanism of CTPR proteins, which will be explored in this PhD thesis. 
 
Figure 13 Fraction folded vs T (A) or [GdnHCl] (B) for CTPR constructs containing 2-10 repeats 
[Kajander, T. et al. 2005]. 
 
 
Figure 14 CD spectra of CTPR8 at increasing GuHCl concentrations showing PPII helical structure. 
The inset shows CD spectra of CTPR8 at 6 M GuHCl at 25°C (solid line), at 98°C (dashed and dotted 
line) and at 25°C after the sample was heated and cooled down (dashed line). 
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Aim of the work 
Chemical modification of proteins with biophysical probes appears an extremely 
valuable tool for investigating and characterizing the molecular mechanisms 
controlling biological phenomena, such as protein folding. For long time the 
difficulties associated with the site-specific introduction of more than one probe into a 
protein have hindered the implementation of such approach. The introduction of 
Chemical Ligation methods represents a key event in this field, allowing the site-
specific labeling of proteins with a broad range of molecular probes. Chemical ligation 
strategies in combination with standard biophysical techniques have greatly improved 
our ability to understand protein function, structure and folding mechanism 
[Muralidharan, V. & Muir, T.W. 2006]. This PhD thesis describe a useful and general 
protocol based on the use of EPL for the preparation of proteins site-specifically 
functionalized at multiple sites. The power of the semisynthetic protocol developed 
was demonstrated through the production of a series of CTPR3 protein variants in 
which two fluorophores were incorporated at different and specific positions, to allow 
the conduction of FRET experiments. The four doubly labeled variants prepared were 
named CTPR3[1_C], CTPR3[2_C], CTPR3[N_C] and CTPR3[1_3] depending on the 
location of the two fluorophores (for instance, the construct CTPR3[1_C] harbors the 
two fluorofores of the pair respectively in the first CTPR motif and at C-terminus). 
Besides, this PhD thesis reports the results of preliminary biophysical studies 
performed by CD and ensemble-FRET on the obtained labeled constructs. The semi-
synthetic strategy proposed is generally applicable to the preparation of proteins in 
which a combination of two different labels is incorporated at any desired position 
within the protein. The approach described, moreover, could be adapted to the 
introduction of more than two probes and could be used for a wide range of 
applications not only in biophysics but even in biotechnology. 
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EXPERIMENTAL SECTION 
 
MATERIALS AND INSTRUMENTS 
pTXB1 (Fig. 15A) and pETM13 (Fig. 15B) plasmids were respectively obtained from 
New England Biolabs and European Molecular Biology Laboratory. pProEXHTa 
vector (Fig. 15C) containing the gene construct coding CTPR3 (360 bp) cloned 
between BamHI and HindIII sites (pProExHTa-ctpr3) was provided by Prof. Lynne 
Regan from the Department of Molecular Biophysics and Biochemistry of Yale University 
(New Haven, CT-USA). All restriction and modification enzymes were purchased from 
New England Biolabs, except for PfuTurbo DNA Polymerase (Stratagene) and 
restriction enzyme SacI (Roche). Molecular weight markers for nucleic acids and 
loading dye for the preparation of DNA samples were supplied by NEB and Roche. 
DNA purification kits were purchased from Qiagen. The synthesis of the 
oligonucleotides was committed at Sigma-Genosys, while plasmids sequencing was 
committed at Primm. E. coli TOP F‟10 and DH5α strains, used for cloning, were 
supplied by Invitrogen, while cell strain BL-21(DE3), used for proteins expression, 
was purchased from Novagen (Merck). Isopropylbeta-D-thiogalactopyranoside 
(IPTG) was from Inalco. Protease inhibitor phenylmethanesulfonyl-fluoride (PMSF) 
was obtained from Sigma-Aldrich. Protein molecular weight markers, reagents for the 
preparation of bacterial growth media, buffers, polyacrylamide and agarose gel 
electrophoresis were provided from Sigma-Aldrich and Applichem. Fluorophores 
ATTO 647N-maleimide and ATTO 488-maleimide were purchased from ATTO-
TECH. L-cysteine and 2-mercapto-ethane sulfonate sodium (MESNA) were 
purchased from Sigma-Aldrich, while tris(2-carboxyethyl)phosphine (TCEP) from 
STREMM. Fmoc-protected amino acids and coupling reagents for peptide synthesis 
were purchased from InBios and AnaSpec. Fmoc-Gly-Wang resin was provided by 
NovaBiochem (Merck). N,N-diisopropylethylamine (DIPEA) was provided from Romil, 
while piperidine was purchased from Biosolve. Acetic anhydride was supplied by 
Sigma-Aldrich. Other solvents for peptide synthesis and purification 
(dimethylformamide, N-methyl-2-pyrrolidone, dichloromethane, trifluoroacetic acid, 
ethandithiol, triisopropyl silane, diethyl ether, acetonitrile) were from Sigma-Aldrich or 
Romil. All reagents and solvents were used without further purification. 
PCR reactions were performed on an Eppendorf Mastercycler personal apparatus. 
Electroporation was carried out in M-Medical cuvettes with an electrode gap of 0.2 
cm and using a Bio-Rad Gene Pulser XcellTM electroporator. Cell lysis was carried 
out using a Misonix Sonicator 3000. 0.22 μm polyvinylidene difluoride (PVDF) filters 
were acquired from Millipore. Dialysis membrane was from Spectra/Por. HisTrap 
affinity chromatography columns and ÄKTA FPLC system were from GE HealthCare. 
Polyacrylamide and agarose gel were visualized using a Chemi doc XRS apparatus 
(Bio-Rad). Analytical characterization of peptide and proteins was performed on an 
LC-MS system comprising an LCQ DECA XP ion trap mass spectrometer 
(ThermoElectron) equipped with an ESI source and a complete Surveyor HPLC 
system (including MS pump, autosampler and photo diode array [PDA]). The LC-MS 
analysis of peptide and proteins was carried out on a Jupiter C18 column, 5 µm, 300 
Ǻ, 250 x 2.0 mm (Phenomenex). Purifications by HPLC were performed on an HP 
1200 Series (Agilent Technologies) using a Jupiter C18 column, 10 µm, 250 x 22 mm 
(Phenomenex),  Jupiter C18 column, 10 µm, 250 x 10 mm (Phenomenex) and a 
Proteo C12 column, 10 µm, 250 x 22 mm (Phenomenex). Methods used for the 
analyses and purifications are specified in the following paragraphs. UV-VIS spectra 
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were recorded on a Jasco V-550 UV-Vis spectrophotometer and quartz cuvettes with 
a path length of 1 cm. Circular Dicroism (CD) analyses were performed on AVIV 
Model 215 CD spectophotometer (AVIV Instruments) and an Applied Photophysics 
Chirascan CD spectrometer (Applied  Photophysics) equipped with Peltier 
temperature controller. Fluorescence spectra were recorded using a PTI 
Quantamaster C-61 two channel fluorescence spectrophotometer (Photon 
Technology International). CD and fluorescence analyses were performed using 
quartz cuvette with path length of 0.3 cm. 
 
 
 
Figure 15 Structural organization of pETM13 (A), pTXB1 (B) and pProEXHTa (C) plasmids. 
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METHODS 
Antibiotics  
Ampicillin and kanamycin (commercially available as ampicillin sodium salt and 
kanamycin sulphate) were solubilized in deionized water at a concentration of 1000X, 
filter sterilized and stored at –20°C until use. Ampicillin was used at a concentration 
of 100 μg/mL while kanamycin was used at a concentration of 50 μg/mL in both solid 
and liquid media. 
 
Solid and liquid media for bacterial strains  
LB broth was prepared as follows: 10 g/L tripton, 5 g/L yeast extract, 10 g/L NaCl. 
Solid medium was prepared dissolving complete LB-agar powder in deionized water 
at a concentration of 40 g/L. Culture media were supplemented with antibiotic. 
 
Preparation of E. coli TOP F’10 competent cells and transformation by 
electroporation 
2.5 mL of an overnight culture of E. coli TOP F‟10 cells were inoculated into 250 mL 
of LB medium. The cells were grown up to mid-log phase (0.6 OD600nm) at 37°C, 
stored on ice for 20-30 min and then harvested by centrifugation (6000 rpm, 10 min, 
4°C). The pellet was washed in 250 mL of sterile water. After the second 
centrifugation the cells were washed in 125 mL of sterile water. The third washing 
was performed in 5 mL of 10% glycerol; the cells were then harvested by 
centrifugation and the pellet was resuspended in 750 μL of 10% glycerol. Aliquots of 
30 μL were mixed with 1.5 μL of ligase reaction, incubated for 1 min on ice and 
transferred into chilled plastic cuvettes. High voltage electroporation (25 μF) was 
performed at a field strength of 2.5 kV/cm and 200 Ohm. A shock pulse was applied 
to competent cells producing pulse length of ~5.0-5.5 ms. Immediately after 
electroporation cell mixtures were diluted to 1 mL with LB medium and incubated for 
~1 h at 37°C under shaking. The cells were then plated onto selective solid medium 
supplemented with 100 μg/mL ampicillin or 50 μg/mL kanamycin to isolate the 
recombinant clones. Single clones were inoculated in 10 mL LB medium with the 
same antibiotics and grown overnight at 37°C under shaking. Finally, cells were 
harvested by centrifugation (7,000 rpm, 10 min, 4°C) and processed to extract 
plasmidic DNA by using the QIAprep Spin Miniprep Kit or the QIAGEN plasmid Maxi 
Kit. 
 
Preparation of E. coli competent cells and transformation by heat shock  
Single clone of BL-21(DE3) or DH5α E. coli strain, grown at 37°C in LB-agar, was 
inoculated into 2.5 mL of LB medium and incubated overnight at 37°C on a shaker. 
The cells were inoculated into 250 mL of LB medium and the culture was grown up to 
mid-log phase (0.6 OD600) at 37°C, stored on ice for 20-30 min and then harvested by 
centrifugation (6000 rpm, 10 min, 4°C). The pellet was washed in 125 mL of cold 50 
mM CaCl2 and stored on ice for 30 min. Successively, cells were harvested by 
centrifugation and the pellet resuspended in 16 mL of cold 50 mM CaCl2. Aliquots of 
200 μL of competent cells were mixed with 50 ng of plasmidic DNA or 10 μL of ligase 
reaction mix and stored on ice for ~30 min. The cells were transferred at 42°C for 45 
sec, on ice for 2 min (heat shock) and then diluted to 1 mL with LB medium. An 
incubation for ~1 h at 37°C under shaking was performed before plating the cells 
onto solid medium supplemented with the opportune antibiotic. 
 
 
44 
 
Electrophoretic analysis of DNA 
DNA samples were prepared in 1X loading dye and then loaded on 1% or 2% 
agarose gel prepared in TAE buffer 1X (1 mM EDTA, 40 mM Tris base. Add acetic 
acid until pH 7.8) and containing 5 µg/mL ethidium bromide. Electrophoresis was 
performed in the same buffer TAE 1X for 30 min at 100V.  
  
Electrophoretic analysis of proteins (SDS-PAGE)  
The electrophoresis on polyacrylamide gel in the presence of sodium dodecyl sulfate 
(SDS-PAGE) was performed according to Laemmli‟s protocol [Laemmli, U. 1970]. 
The samples were denatured at 100°C for 10 min in loading buffer (1% SDS, 0.001% 
bromophenol blue and 10% glycerol) without β-mercaptoethanol. The samples were 
then loaded on a 15% polyacrylamide gel and electrophoresed in running buffer 1X 
(0.025 M Tris-HCl, 0.2 M glycine pH 8.3 and 0.1% SDS). The proteins were then 
revealed by Coomassie Brilliant-Blue staining; the gel was first submerged in the 
prestaining solution (20% ethanol, 10% acetic acid) and then in the staining solution 
(0.01% Coomassie Brilliant-Blue R250, 5% ethanol, and 7.5% acetic acid) with gentle 
agitation. The gel was finally washed in H2O to remove the excess of Coomassie.  
 
Determination of the protein concentration 
The concentration of proteins in solution was determined according to the Bradford‟s 
method [Bradford, M. 1976]. The Coomassie Brilliant (Bio-Rad) reagent was added to 
the samples and the absorbance at 595 nm was recorded. A solution of 1.5 μg/μL of 
bovine serum albumin (BSA) was used as standard. Protein concentration was also 
measured by UV spectroscopy, reading the tryptophan absorbance at 280 nm. 
Labeled proteins concentration was estimated by UV-Vis spectroscopy, detracting 
from the absorbance at 280 nm the contribution of the fluorophore/s, using the 
following equation: 
 
 
 
where CF are correction factors suggested by the fluorophores manufacturer (ATTO 
647N-maleimide CF 0.05; ATTO 488-maleimide CF 0.1).  
 
Bioinformatic tools 
Protein sequences were processed using ProtParam tool available on the ExPASy 
Server (http://www.expasy.ch), in proteomics tools section. The tool was used to 
compute pI (isoelectric point), Mw (molecular weight) and ε (extinction coefficient) of 
proteins. 
 
Cloning procedure 
Introduction of the mutations Asn36Cys or Asn70Cys into ctpr3 gene 
pProExHTa-ctpr3 plasmid was mutagenized by cassette-mutagenesis to introduce 
mutations Asn36Cys or Asn70Cys into ctpr3 gene. To this purpose, pProExHTa-ctpr3 
plasmid was co-digested with restriction enzymes XhoI and SacI or SacI and HindIII 
to extract gene cassettes including respectively Asn36 or Asn70 codon next to their 
5‟ termini. Each co-digestion was performed on 30 μg of the recombinant plasmid 
pProExHTa-ctpr3 in 33 mM Tris acetate, 10 mM magnesium acetate, 66 mM 
potassium acetate, 0.5 mM dithiothreitol pH 7.9, for 2.5 h at 37°C using 4 
Uenzyme/μgDNA. Excised cassettes (111 bp or 167 bp respectively) and digested 
vectors were extracted from agarose gel using the QIAquick Gel Extraction Kit. Gene 
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cassettes were then mutagenized by PCR using sense primers including the 
mutation Asn36Cys or Asn70Cys as well as XhoI or SacI site, and antisense primers 
including SacI or HindIII site (Table I). The mutagenic PCR reactions were performed 
in a total volume of 50 μL containing 50 ng of gene-cassette preparation as template, 
30 pmol of each primer, 250 μM dNTP, 2.5 U (1 µL) of PfuTurbo DNA polymerase in 
the supplied buffer 1X. PCR reactions were performed following the procedure 
indicated below: 
 
Initial denaturation step 3 min at 95°C 
 
Denaturation (step 2) 1 min at 95°C 
Annealing (step 3) 1 min at the convenient temperature for each primers pair  
Elongation  1 min at 72°C 
from step 2 for 30 cycles  
 
Final elongation (step 4)  15 min at 72°C 
 
PCR products were purified by using the QIAquick PCR Purification Kit, digested with 
XhoI and SacI or SacI and HindIII in the conditions described before in this 
paragraph and subcloned into pProExHTa-ctpr3 vector between the same restrictions 
sites. Ligation reactions were carried out in a total volume of 10 μL, using 100 ng of 
the digested plasmid, a three and five fold molar excess of the insert, 1 μL of 400 
U/μL T4 DNA ligase in the supplied buffer 1X. Ligation mixtures were incubated 3 h 
at room temperature and then 1.5 μL of each mixture was transformed by 
electroporation in competent E. coli TOP F‟10 cells, following the transformation 
protocol described before in this section. After transformation, cells were plated onto 
LB-agar plates supplemented with ampicillin. The day after, clones obtained on 
plates were screened by colony-PCR. Clones were resuspended in 20 μL of sterile 
water and 5 μL of each cell suspension was used as template in PCR reactions. PCR 
was carried out in the same conditions and with the same primers adopted for 
mutagenic PCR before described. The remaining 15 µL of cell suspension of each 
positive clone were inoculated in 10 mL of LB supplemented with ampicillin and 
incubated at 37°C overnight. Recombinant plasmids were isolated from cells using 
QIAprep Spin Miniprep Kit and verified by sequencing.  
 
Table I PCR primers used for the introduction of mutations Asn36Cys and Asn70Cys into CTPR3 
coding gene. 
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Preparation of the genes coding CTPR3 variants and Mxe GyrA intein 
For the variant CTPR3[1_3], the gene trait corresponding to amino acids 1-104 of 
CTPR3 (312 bp) was amplified from pProExHTa-ctpr3(Asn36Cys). Instead, for 
CTPR3[1_C] and CTPR3[2_C] variants, the full ctpr3 gene (360 bp, 120 amino acids) 
containing the mutation Asn36Cys or Asn70Cys was respectively amplified from 
mutagenic plasmids pProExHTa-ctpr3(Asn36Cys) and pProExHTa-ctpr3(Asn70Cys). 
For CTPR3[N_C] variant preparation, the full ctpr3 gene was amplified directly from 
wild-type pProExHTa-ctpr3 using a sense primer containing an extra Cys codon (Cys 
-1). To preserve NcoI site upstream the gene an extra Gly residue in position -2 was 
also added. All the above mentioned genes were amplified using sense primers 
including NcoI restriction site and antisense primers designed to generate a 3‟ 
terminal region of 15 bp overlapping the gene of the Mycobacterium xenopi DNA 
gyrase A intein (Mxe GyrA intein) (Table II).  
 
Table II PCR primers used for the amplification of CTPR3 variants gene. 
The gene coding Mxe GyrA intein (594 bp) was amplified from pTXB1 vector using 
sense primers generating a 5‟ terminal region of 15 bp overlapping CTPR3 variant 
coding genes and an antisense primer including EcoRI restriction site (Table III). 
 
Table III PCR primers used for the amplification of Mxe GyrA intein gene. 
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All PCR reactions were performed as described in the previous paragraph, using the 
polymerase PfuTurbo which is endowed of 3‟-5‟ exonuclease activity. After 
amplification, all the genes were purified using QIAquick PCR Purification Kit. 
Fusion genes construction by Overlapping Extension PCR 
Hybrid genes coding the CTPR3 variants fused to Mxe GyrA intein were obtained by 
Overlapping Extension PCR. Each reaction was performed in a total volume of 100 
μL using 50 ng of Mxe GyrA gene and an equimolar amount of the CTPR3 gene 
variant, 250 μM dNTPs, 2.5 U (1 µL) of PfuTurbo DNA polymerase, 2.5% formamide, 
PfuTurbo buffer 1X. Before adding the two primers, 5 cycles of template extension 
were performed as follows:  
 
Initial denaturation step 3 min at 95°C 
 
Denaturation (step 2)  1 min at 95°C 
Annealing (step 3)   1 min at 55°C  
Elongation   1 min at 72°C 
for 5 cycles from step 2 
 
Final elongation (step 4)  15 min at 72°C 
 
Then, 30 pmol (3 µL of a 10 µM dilution) of each of the two primers annealing 5‟ 
terminus of CTPR3 variant coding gene and 3‟ terminus of Mxe GyrA were added to 
the PCR reaction and 25 cycles of amplification were performed as follows: 
 
Initial denaturation step 3 min at 95°C 
 
Denaturation (step 2) 1 min at 95°C 
Annealing (step 3) 1 min at the convenient temperature for each primers pair 
Elongation  1 min at 72°C 
for 25 cycles from step 2 
 
Final elongation (step 4)  15 min at 72°C 
 
PCR mixtures were then separated on a 2% agarose gel and the fragments 
corresponding to the fusion genes were extracted from agarose gel using QIAquick 
Gel Extraction Kit. Fusion genes were then digested with NcoI and EcoRI restriction 
enzymes. Digestions were performed in 20 mM Tris acetate, 10 mM magnesium 
acetate, 50 mM potassium acetate, 1 mM dithiothreitol pH 7.9, for 2.5 h at 37°C using 
4 Uenzyme/μgDNA. Similarly, also the expression vector pETM13 was digested with the 
restriction enzymes NcoI and EcoRI and treated with calf intestine phosphatase (CIP, 
10U) for 1 h at 37°C in the supplied buffer (50 mM Tris-HCl, 100 mM NaCl, 
10 mM MgCl2, 1 mM dithiothreitol pH 7.9) to remove 5‟ phosphoryl groups. Digested 
fusion genes and vector were purified and, finally, fusion genes were cloned into 
pETM13 upstream an His6-tag coding sequence. Ligation mixtures were prepared as 
before described in this text and transformed in chemically competent E. coli DH5α 
cells. Cells were spread on LB-agar supplemented with kanamycin. Positive clones 
were screened by colony-PCR as yet described and sequenced.  
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Expression procedure 
Recombinant pETM13 plasmid harboring chimeric DNA coding CTPR3 variant fused 
to Mxe GyrA intein was transformed in chemically competent E. coli BL-21(DE3) 
cells. Cells were plated on LB-agar supplemented with kanamycin and incubated 
overnight at 37°C. A single colony was inoculated in 25 mL of LB media with 
kanamycin and incubated overnight a 37°C while shaking. The small scale culture 
was used to inoculate 1 L of LB media at 0.06 OD600nm; the culture was incubated at 
37°C until the OD600nm reached 0.7-0.8, then transferred at 22°C and induced with 
0.5 mM IPTG allowing the expression of the fusion protein to proceed overnight. The 
cells were then harvested by centrifugation at 7,000 rpm, 10 min at 4°C and stored at 
-20°C. 
 
Thioester proteins purification procedure 
Pellet from 1 L culture was resuspended in 50 mL of ice-cold 50 mM phosphate 
buffer pH 6.5, 300 mM NaCl, 10 mM imidazole (buffer A) containing 1 mM proteases 
inhibitor PMSF. The cells were lysated by sonication and the crude extract was 
centrifuged at 16,000 rpm for 30 min at 4°C. The supernatant, containing the soluble 
His6-tagged fusion protein, was filtered using a 0.22 μm PVDF filter and loaded onto 
a 5 mL HisTrap column pre-equilibrated in buffer A. The purification was performed 
using an ÄKTA FPLC system at 4°C. After soluble fraction loading, the column was 
extensively washed with buffer A (1 mL/min) until reaching UV baseline. Then, fusion 
protein was eluted from resin with 50 mM phosphate buffer pH 6.5, 300 mM NaCl, 
500 mM imidazole (buffer B) (1 mL/min) and immediately incubated at 4°C, under 
mild stirring, with 50 mM MESNA. After splicing, the proteins mixture was extensively 
dialyzed in 5 mM phosphate buffer pH 6.5, using a membrane of molecular cut-off of 
6-8 kDa, and then lyophilized. The lyophilized proteins mixture was resuspended in 
20% CH3CN, 0.1% TFA in water and incubated with 20 mM TCEP to reduce Cys 
residues. C-terminal thioester derivative of the CTPR3 variants were isolated by 
reverse-phase HPLC using a Jupiter C18 column, 10 µm, 250 x 22 mm performed at 
a flow rate of 20 mL/min. Thioester protein CTPR3[1_3]-fragment 1-104 was purified 
using a step-gradient of CH3CN (TFA 0.1%) in H2O (TFA 0.1%) from 20% to 30% in 
3 min and from 30% to 40% in 20 min; thioester proteins CTPR3[1_C] and [N_C] 
were purified using a step-gradient of CH3CN (TFA 0.1%) in H2O (TFA 0.1%) from 
20% to 29% in 5 min and from 29% to 33% in 30 min; thioester protein CTPR3[2_C] 
was purified using a step-gradient of CH3CN (TFA 0.1%) in H2O (TFA 0.1%) from 
20% to 29% in 3 min and from 29% to 36% in 20 min. Collected fractions were 
analyzed by LC-mass spectrometry using a Jupiter C18 column, 5 µm, 300 Ǻ, 250 x 
2.0 mm using the same methods adopted for proteins purification before described 
and a flow rate of 0.2 mL/min. Fractions containing pure CTPR3 variants as MESNA 
C-terminal thioester were pooled and lyophilized. 
 
Cys-Peptide (CTPR3[1_3]-fragment 105-120) synthesis 
Peptide NH2-Cys-Ala-Glu-Ala-Lys-Gln-Asn-Leu-Gly-Asn-Ala-Lys-Gln-Lys-Gln-Gly–
COOH, corresponding to the C-terminal fragment 105-120 of CTPR3[1_3] was 
synthesized on solid phase using a Fmoc-Gly-Wang resin by standard Fmoc 
chemistry. Peptide was synthesized on a 0.1 mmol scale. All the incubation steps 
were performed under stirring. For each coupling reactions were used 10 equivalents 
of the Fmoc-protected amino acid, 9.9 equivalents of Hydroxybenzotriazole (HOBt)/ 
O-Benzotriazole-N,N,N‟,N‟-tetramethyl-uronium-hexafluoro-phosphate (HBTU) and 
20 equivalents of the base DIPEA (1 h each). Removal of Fmoc was carried out with 
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a solution of 30% v/v piperidine in DMF (5 min, twice). After each coupling, unreacted 
N-terminal amino groups were capped with a solution of 2 M acetic anhydride, 0.06 M 
HOBt, 0.55 M DIPEA in NMP (20 min). Between each reaction step, 5 wash of 1 min 
each in DMF were performed to remove exceeding reagent and reaction side-
products. Peptide cleavage from the resin and amino acids side-chain deprotection 
were achieved by treatment with TFA, EDT, triisopropyl silane and water 
(94:2.5:1:2.5) at room temperature for 3 h. Cold diethyl ether was used to precipitate 
the peptide. Crude product was collected by centrifugation, washed twice with cold 
diethyl ether, resupended in water and acetonitrile and lyophilized. The peptide was 
purified by reverse-phase HPLC on a Proteo C12 column, 10 µm, 250 x 22 mm using 
a linear gradient of CH3CN (TFA 0.1%) in H2O (TFA 0.1%) from 5% to 40% in 50 min 
at a flow rate of 20 mL/min. Fractions were analyzed by LC-MS, pooled and 
lyophilized. 
 
First labeling reaction  
Lyophilized thioester proteins were resuspended in 20 mM phosphate buffer, pH 7.2 
at a concentration of 0.25 mM. A two-fold molar excess of the first fluorophore (ATTO 
647N-maleimide) was dissolved in 20 μL of DMF and added to protein. Reaction mix 
was incubated for 2 h at 4°C on the dark, under mild stirring. Then, exceeding 
fluorophore was quenched adding to the reaction mixture a number of µmoles of 
MESNA equal to those of fluorophore added before. Then, the labeled thioester 
proteins were dialyzed in 20 mM phosphate buffer pH 7.2 at 4°C on the dark. 
 
Native Chemical Ligation with L-Cys  
For the preparation of the variants CTPR3[1_C], CTPR3[2_C] and CTPR3[N_C], the 
mono-labeled thioester proteins were incubated overnight at 4°C, on the dark, with a 
20 fold molar excess of L-Cys. After reaction occurred, mono-labeled proteins were 
extensively dialyzed in 20 mM phosphate buffer pH 7.2 to remove the L-Cys excess. 
Mono-labeled proteins were then lyophilized, resuspended in CH3CN 20%, TFA 0.1% 
in water and incubated at 4°C in 20 mM TCEP to reduce C-terminal extra Cys 
residue. After, proteins were purified by reverse-phase HPLC performed using a 
Jupiter C18 column, 10 µm, 250 x 10 mm and a linear gradient of CH3CN (TFA 0.1%) 
in H2O (TFA 0.1%) from 20% to 70% in 40 min at a flow rate of 5 mL/min. Fractions 
were analyzed by LC-MS, pooled and lyophilized. 
 
Native Chemical Ligation with Cys-peptide 
For the preparation of the variant CTPR3[1_3], mono-labeled thioester protein 
corresponding to the first 104 amino acids of the construct was incubated with a 
tenfold molar excess of the Cys-peptide. The composition of the NCL reaction 
mixture was: 0.25 mM mono-labeled thioester CTPR3[1_3]-fragment 1-104, 2.5 mM 
Cys peptide, 100 mM phosphate buffer pH 7.5, 4 M GdnHCl, 1 mM EDTA, 50 mM 
MESNA, 15 mM TCEP. Reaction vessel was closed under N2 and incubated at 4°C 
on the dark with mild stirring. The reaction was monitored by LC-MS and allowed to 
proceed until the disappearance of the thioester protein peak. After, the NCL reaction 
mixture was diluted 1:2 with H2O and extensively dialyzed in 20 mM phosphate buffer 
pH 7.2. Mono-labeled full protein was then lyophilized, resuspended in 20% CH3CN, 
0.1% TFA in water, reduced with 10 mM TCEP and purified by HPLC as before 
described for the other constructs on a Jupiter C18 column, 10 µm, 250 x 10 mm at a 
flow rate of 5 mL/min. CTPR3[1_3] labeled with 647N on Cys36 was purified using a 
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gradient of CH3CN (TFA 0.1%) in H2O (TFA 0.1%) from 10% to 40% in 5 min and 
from 40% to 50% in 40 min. 
 
Second labeling reaction 
Single labeled constructs were dissolved in 20 mM phosphate buffer pH 7.2 and 
reacted with the second fluorophore of the FRET pair. The second labeling reaction 
(performed with fluorophore ATTO 488-maleimide) occurred on the Cys residue 
involved in the NCL reaction (C-terminal Cys for CTPR3[1_C], [2_C] and [N_C]; 
Cys105 for CTPR3[1_3]). Second labeling was carried out in the same experimental 
conditions described for the first labeling reaction. After reaction, exceeding label was 
quenched with MESNA as described for the first labeling. Finally, doubly labeled 
proteins were newly dialyzed in 20 mM phosphate buffer pH 7.2 and lyophilized. 
Doubly labeled proteins were then resuspended in 20% CH3CN, 0.1% TFA in water 
and all purified by reverse-phase HPLC using a Jupiter C18 column, 10 µm, 250 x 10 
mm performed at a flow rate of 5 mL/min. Doubly labeled variant CTPR3[1_C] and 
CTPR3[2_C] were purified using a linear gradient of CH3CN (TFA 0.1%) in H2O (TFA 
0.1%) from 20% to 70% in 30 min. Doubly labeled CTPR3[N_C] was purified  using a 
gradient of CH3CN (TFA 0.1%) in H2O (TFA 0.1%) from 20% to 70% in 25 min. 
Doubly labeled CTPR3[1_3] was purified using a gradient of CH3CN (TFA 0.1%) in 
H2O (TFA 0.1%) from 20% to 70% in 50 min. Fractions were analyzed by LC-MS and 
those containing the doubly labeled protein were pooled and lyophilized.  
 
Control constructs preparation 
Control constructs harboring only the donor or the acceptor fluorophore or none of 
them were also prepared using the same approach adopted for the preparation of the 
doubly-labeled species. Unlabeled proteins containing the two Cys residues in the 
same position as the doubly labeled proteins were obtained carrying out NCL 
reactions between unlabeled thioester moieties and L-Cys or Cys-peptide as 
described for the preparation of the labeled analogs. For the preparation of unlabeled 
CTPR3[1_C] and CTPR3[2_C], after NCL, proteins were reduced with 10 mM TCEP, 
extensively dialyzed in 5 mM phosphate buffer pH 7.2 and lyophilized. A further 
purification step was not necessary, due to the homogeneity of the sample obtained. 
CTPR3[N_C] unlabeled protein was not prepared because this variant does not 
contain internal mutations but only insertions at N- and C-termini and we assume it to 
retain the same stability of the wild-type protein. For the preparation of unlabeled 
CTPR3[1_3], after NCL with the Cys-peptide, the protein was dialyzed in 5 mM 
phosphate buffer pH 7.2 and lyophilized. Protein was resuspend in 20% CH3CN, 
0.1% TFA in water, reduced with 10 mM TCEP and purified to homogeneity by 
reverse-phase HPLC using a Jupiter C18 column, 10 µm, 250 x 10 mm, performed at 
5 mL/min and using a step gradient from 20% to 30% in 3 min and from 30% to 55% 
in 30 min. Mono-labeled proteins, containing only the first fluorophore of FRET pair 
ATTO 647N in position N-terminal, 36 or 70 and the second Cys free, were prepared 
concomitantly with the preparation of the doubly-labeled variants. The control 
construct containing only the second fluorophore of the pair, ATTO 488, at C-terminal 
position was prepared expressing the wild-type CTPR3 protein as fusion construct 
with Mxe GyrA intein; thioester CTPR3, which does not contain Cys residues, was 
reacted in NCL reaction with L-Cys, adding a single Cys residue at the C-terminus. 
Cys was labeled with ATTO 488 similarly as before described and purified by reverse 
phase HPLC using a linear gradient of CH3CN (TFA 0.1%) in H2O (TFA 0.1%) from 
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20% to 45% in 45 min on a Jupiter C18 column, 10 µm, 250 x 10 mm, performed at 5 
mL/min. Pure fractions were pooled and lyophilized. 
 
Spectroscopic characterization of CTPR3 variants 
 
CD analyses 
All CD experiments were performed in 50 mM phosphate buffer, 150 mM NaCl pH 
7.0 and acquired in the far UV range 190-260 nm. The CD spectra were recorded at 
a protein concentration of 3 μM, at 25°C, with a band width of 1 nm, a step of 1 nm 
and a time per point of 3 sec, in a 0.3 cm path length cuvette. Each CD spectrum was 
corrected for buffer blank obtained under identical conditions.  
Thermal denaturation was monitored by following the ellipticity signal of the helical 
structure at 222 nm from 10°C to 94°C and in the reverse direction from 94°C to 
10°C. The temperature ramp was performed in 1°C steps with an equilibration time at 
each temperature of 1 min. The estimation of protein unfolded fraction content at 
each temperature was evaluated giving 0% value to mdegree registered in the native 
state (10°C) and 100% value to mdegree estimated in the unfolded state (94°C). 
Chemical denaturation experiments were performed at 25°C, using urea or GdnHCl 
as denaturant. 150 µL of sample at protein concentration of 10 µM was titrated with 
50 mM phosphate buffer, 150 mM NaCl, containing 9 M urea or 7 M GdnHCl. At each 
titration point the concentration of urea or GdnHCl was increased by 0.25 M and the 
sample was equilibrated for 2 min before acquiring the CD spectrum. Ellipticity at 222 
nm was corrected considering the dilution factor. The estimation of protein unfolded 
fraction content at each titration point was evaluated giving 0% value to mdegree 
registered in the native state (0 M [urea] or [GdnHCl]) and 100% value to mdegree 
estimated in the unfolded state (8.25 M [urea] or 5 M [GdnHCl]). 
 
FRET analyses 
All fluorescence spectra were acquired at 25°C. The sample was excited at 503 nm 
with a 2 nm slit, and the fluorescence emission was recorded between 505 nm and 
700 nm through a 2 nm slit. To minimize sample variability effects, CD and FRET 
chemical denaturation experiments were performed on the same sample and in the 
same cuvette with path length of 0.3 cm, recording before the fluorescence spectrum 
and immediately after CD spectrum at each GdnHCl or urea concentration. Chemical 
denaturation experiments were performed at 25°C, using urea or GdnHCl as 
denaturant. 150 µL of sample at protein concentration of 10 µM was titrated with 50 
mM phosphate buffer, 150 mM NaCl, containing 9 M urea or 7 M GdnHCl. At each 
titration point the concentration of urea or GdnHCl was increased by 0.25 M and the 
sample was equilibrated for 2 min before acquiring the fluorescence spectrum. At 
each titration point, fluorescence intensities of donor and acceptor fluorophores at 
their emission maximum wavelengths were recorded and their ratio was used to 
estimate unfolded protein content at each denaturant concentration values. Acceptor 
fluorophores ATTO 647N emission maximum was observed at 669 nm; donor 
fluorophores ATTO 488 emission maximum was recorded at 523. Fluorescence 
intensities ratio at 0M [urea] or [GdnHCl]) was correlated to 0% unfolded fraction, 
while the same ratio at 5 M GdnHCl or 8.25 M urea was associated to 100% unfolded 
fraction. Titration with the denaturant caused a slight deviation of emission maximum 
wavelengths from these values. 
For the analysis of FRET data the following equations were considered. The 
efficiency of the nonradiative FRET process (E) is given by: 
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  [1] 
 
where R is the donor–acceptor distance and R0 is the Förster radius, defined to be 
the distance at which E is 50%. To relate fluorescence intensities of the donor and 
acceptor to FRET efficiency, the following expression was used: 
 
   [2] 
 
where  and  correspond to the acceptor and donor fluorescence intensities, 
respectively, when the donor is excited, and  is correction factor for the quantum 
yield and the detector efficiency described as: 
 
  [3] 
 
where and corresponds to the detector corrections for acceptor and donor while 
a and d are the fluorescence quantum yields for the donor and acceptor of the 
aceptor and donor. In the system used for the experiments,  values for ATTO labels 
was assumed 1. By equating expressions 1 and 2, the donor–acceptor distance  R 
can be measured. 
 
Fluorescence anisotropy assays 
Fluorescence anisotropy studies were performed in 50 mM phosphate buffer, 150 
mM NaCl pH 7.0 at 3 µM protein concentration in a 0.3 cm path-length cuvette at 
25ºC. To perform fluorescence anisotropy experiments the fluorescence 
spectrophotometer (reported in Material and Instrument paragraph of this section) 
was equipped with excitation and emission polarizers. ATTO 647N excitation was 
accomplished with a 4 nm slit-width at 647 nm and the emission recorded at 669 nm 
with slit widths of 4 nm. ATTO 488 excitation was accomplished with a 4 nm slit-width 
at 495 nm and the emission recorded at 521 nm with slit widths of 4 nm. 
G-factor corrections to account the difference in transmission efficiencies of the two 
emission channels were applied to calculate anisotropy using the equation: 
 
 
 
 
where IHV is the vertical emission (0º) of a standard solution of free fluorophore with 
excitation in horizontal orientation (90º), IHH is the horizontal emission of a standard 
solution with excitation in horizontal orientation, IB,HV is the vertical emission of a 
blank solution with excitation in horizontal orientation and IB,HH is the horizontal 
emission of a blank solution with excitation in horizontal orientation. For excitation at 
vertical orientation (0º) the expression for anisotropy (r) containing the G-factor is: 
HHBHH
HVBHV
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where G is the G-factor, IVV and IVH are the vertical and horizontal emission of the 
sample, respectively, and IB,VV and IB,VH the intensity of emission of the blank with 
emission polarizer at vertical and horizontal orientation, respectively. 
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RESULTS AND DISCUSSION 
 
Semisynthetic approach 
The strategy developed for the preparation of doubly-functionalized proteins is 
schematically illustrated in Fig. 16.  
 
 
Figure 16 Schematic representation of the semisynthetic strategy adopted for the production of 
doubly-labeled proteins. Strategy A) Approach adopted for the preparation of a protein carrying both 
probes inside the sequence. The N-terminal portion of the protein was produced as C-terminal 
thioester through the expression with the Mxe GyrA intein as fusion partner. After purification, the N-
terminal fragment of the protein of interest, carrying a C-terminal thioester group, was labeled with the 
first probe and then reacted by NCL with a chemically synthesized peptide corresponding to the C-
terminal remaining portion of the protein and containing an N-terminal Cys residue. Cys involved in 
NCL was then used for the site-specific labeling with the second probe. Strategy B) Approach 
adopted for the preparation of proteins carrying the second probe at C-terminus. The full protein was 
expressed as fusion construct with the intein and after thioester purification and labeling with the first 
molecular probe, the protein was reacted by NCL with L-Cys, so that an extra-sequence Cys residue 
was inserted at C-terminus. C-terminal Cys was finally used for the second labeling. 
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The approach is based on the use of the Expressed Protein Ligation (EPL) and 
requires the splitting of the protein of interest in two fragments. The N-terminal 
fragment, containing a single Cys residue, is expressed in bacterial host as fusion 
protein with the Mycobacterium xenopi Gyrase A intein (Mxe GyrA intein). The 
expressed chimeric protein is also endowed of a C-terminal His6 tag, allowing its 
purification by affinity chromatography. After purification, the fusion protein is 
incubated with a thiol that induces splicing of Mxe GyrA intein and the release of the 
protein fragment as C-terminal thioester. Thioester protein is then isolated from intein 
and selectively labeled on its single Cys residue with a probe containing a maleimide 
group as sulfhydryl-reactive moiety. Instead, the C-terminal remaining fragment, 
carrying an N-terminal Cys residue, is chemically synthesized. The Native Chemical 
Ligation (NCL) reaction between the mono-labeled thioester fragment and the 
synthetic peptide affords the full-length mono-labeled protein. The Cys residue 
involved in NCL reaction is then exploited to introduce the second probe into the 
protein (Fig. 16 strategy A). A simpler approach could be used when the second 
probe is located at C-terminus of the protein of interest. In this case, the full-length 
protein containing a single Cys at a required position is expressed as intein fusion 
protein. After purification and first labeling, the full-length thioester protein is reacted 
with L-Cys in a NCL reaction. The newly introduced Cys residue is then labeled with 
the second probe (Fig. 16 strategy B).  
A slightly modified protocol of strategy A could allow the preparation of a triple 
labeled protein. In fact, the fragment chemically synthesized and containing the N-
terminal Cys, could be selectively labeled on solid phase in any position. After NCL 
reaction between thioester protein and the synthetic peptide, both carrying a probe, 
the Cys involved in NCL could be used for the introduction of the third probe. 
 
Doubly-labeled CTPR3 protein variants  
The semisynthetic approach proposed was adopted for the preparation of four 
variants of the protein CTPR3 (Fig. 17) labeled with a fluorophores pair. The variants 
are schematically represented in Fig. 17C and are named CTPR3[1_3], CTPR3[1_C], 
CTPR3[2_C] and CTPR3[N_C]. The nomenclature adopted indicates the protein 
regions in which the fluorescent probes (an acceptor and a donor) are located. The 
variants differ for the distance between the two fluorophores and for the localization 
in internal vs peripheral protein regions, useful for the folding studies by FRET. In 
CTPR3[1_3] variant (Fig. 17C, #1), the two fluorophores were respectively placed in 
the first and third CTPR motif (amino acid sequence positions 36 and 105). Among 
the variants prepared, CTPR3[1_3] exhibits the shortest spatial distance between the 
fluorophores (28.4 Å, from CTPR3 x-ray structure; pdb code:1NA0) and is the only 
construct harboring both fluorophores on internal regions of the protein. The other 
three variants exhibit at least one of the probes on terminal protein regions. In fact, 
CTPR3[1_C] (Fig. 17C, #2) and CTPR3[2_C] (Fig. 17C, #3) constructs bear only the 
first probe on internal protein region, respectively in the first and second CTPR motif 
(position 36 and 70 respectively), while the second probe is placed at C-terminus 
(position 121). The distance between fluorophores is 40.3 Å in CTPR3[1_C] and 31.3 
Å in CTPR3[2_C] variant. CTPR3[N_C] (Fig. 17C, #4) presents both fluorophores in 
the terminal protein regions, the first probe at N-terminus while the second at C-
terminus (position -1 and 121). CTPR3[N_C] shows the higher spatial distance 
between the fluorophores (52.0 Å). 
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Figure 17 A) Schematic representation of CTPR3 wild-type. The protein contains three identical 
repeats of the 34 amino acids consensus TPR module flanked by a N-terminal cap sequence and a C-
terminal solvating extra-helix. B) Ribbon representation of CTPR3, PDB ID 1NA0 crystal structure. C) 
Schematic representation of the doubly-labeled CTPR3 variants prepared by the semisynthetic 
approach. The doubly-labeled variants differ for fluorophores location, which could be placed inside 
the protein or in the terminal regions. 
 
 
CTPR3[1_3] variant preparation 
 
The strategy A illustrated in Fig. 16 was adopted for the semisynthesis of 
CTPR3[1_3] protein variant (Fig. 17C, #1).  
 
Design of the variant: choice of the sites of labeling 
The sites of labeling were selected in order to assure a minimal perturbation of the 
native protein structure. Therefore, we decided to introduce the two labels in the loop 
regions connecting a repeat with the next one, so that the probes were oriented 
towards the outside of the protein, limiting their effect on protein folding (Fig. 17A and 
B). Among the four amino acids which constitute this loop region (Asp-Pro-Asn-Asn), 
the first Asn residue is associated with the lowest global propensity value for that 
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position [Main, E.R.G. et al. 2003] and thus, the mutation of such amino acid should 
not affect significantly native protein structure. Therefore, we selected this residue as 
site of labeling. Accordingly, the first labeling site in the variant CTPR3[1_3] was 
located in position 36, corresponding to the less conserved Asn residue within the 
terminal loop of the first CTPR motif. However, the positioning of also the second 
fluorophore on the correspondent Asn residue in the loop of the third repeat (Asn in 
position 104), in terms of semisynthetic strategy, implies the fusion of the protein 
fragment 1-103, exhibiting a Pro as last amino acid, to the Mxe GyrA intein. Pro 
residue as amino acid directly flanking the Mxe GyrA intein is known to prevent intein 
splicing [Muir, T.W. et al. 2003; Southworth, M.W. et al. 1999]. Thus, in order to 
guarantee the success of the semisynthetic protocol designed, we moved the second 
labeling site to the subsequent amino acid of the loop (Asn in position 105 instead 
than Asn 104). In this way, in fact, the fragment 1-104 had to be fused to the intein, 
and thus an Asn is placed in the splice junction instead than Pro, which assures the 
feasibility of the splicing reaction. Even if the Asn 105 presents a higher global 
propensity value than the precedent Asn 104, it is not included between the “TPR 
signature residues”, allowing the mutation of the residue without the loss of the CTPR 
fold. 
 
Cloning procedure 
The cloning strategy adopted is schematized in Fig. 18. We performed cassette-
mutagenesis on the recombinant pProEXHTa plasmid harboring wild-type CTPR3 
coding gene (pProEXHTa-ctpr3 plasmid), in order to replace with a Cys residue the 
native Asn in position 36, located inside the terminal loop of the first repeat. To this 
purpose, pProEXHTa-ctpr3 plasmid was digested with XhoI and SacI restriction 
enzymes to extract a gene cassette including the Asn 36 codon (Fig. 18A). The 
excised gene cassette was recovered by extraction from agarose gel and then 
mutagenized by PCR, performing the reaction with a forward primer carrying the 
desired mutation. After PCR, the cassette was newly digested with XhoI and SacI 
and subcloned into pProEXHTa-ctpr3 plasmid between the corresponding restriction 
sites. The resulting mutagenic plasmid (pProEXHTa-ctpr3Asn36Cys) was verified by 
sequencing and then used as template in a further PCR reaction by which the gene 
trait corresponding to the first 104 amino acids of CTPR3[1_3] was obtained. The 
PCR was performed employing a forward primer which contained NcoI restriction site 
and a chimeric reverse primer, which added at 3‟ end of the gene trait a region of 
overlap with the gene coding Mxe GyrA intein. Similarly, Mxe GyrA intein gene was 
amplified from pTXB1 plasmid using a forward primer adding at the 5‟ end of intein 
gene a region of overlap with the gene trait coding the N-terminal fragment of 
CTPR3[1_3], and a reverse primer including EcoRI restriction site (Fig. 18B). 
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Figure 18 Schematic representation of the cloning strategy adopted for CTPTR3[1_3] variant 
synthesis. A) Preparation of the mutagenic plasmid pProEXHTa-ctpr3(Asn36Cys) by cassette 
mutagenesis and its use as template for the amplification of gene coding the N-terminal fragment of 
CTPR3[1_3] (amino acids 1-104). B) Construction of the chimeric gene coding the fragment 1-104 of 
CTPR3[1_3] fused to Mxe GyrA intein by Overlapping Extension PCR and cloning in pETM13. 
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After amplification and purification (Fig. 19A), the two genes were mixed in equimolar 
amounts in an Overlapping Extension PCR reaction [Ho, S.N. et al. 1989], in which 
their complementary regions (30 bp) annealed and served as primers for the 
extension of the fusion gene (Fig. 19B).  
 
 
Figure 19 Analysis by agarose gel electrophoresis of: A) gene coding the fragment 1-104 of 
CTPR3[1_3] amplified by PCR on pProEXHTa-ctpr3(Asn36Cys) (lane 1); Mxe GyrA intein gene 
obtained from PCR performed on pTXB1 vector (lane 2); ladder 25 bp (lane 3); B) ladder 100 bp (lane 
1); Overlapping Extension PCR reaction between overlapping genes coding the fragment 1-104 of 
CTPR3[1_3] and Mxe GyrA intein (lane 2). The circle highlights fusion gene band. 
The resulting chimeric gene was recovered by agarose gel extraction, digested with 
NcoI and EcoRI restriction enzymes and cloned into pETM13 vector, upstream an 
His6 tag coding sequence. Recombinant plasmid (pETM13-ctpr3[1_3](fragment 1-
104)- mxe gyra intein) was verified by sequencing and used for fusion protein 
expression.  
By the use of this cloning strategy, no additional amino acids were placed between 
the two components of the fusion protein so that, after intein splicing, the CTPR3 
fragment did not inherit any residual amino acids at its C-terminus. Moreover, His6 
tag was placed at C-terminus of the fusion partner which is a self-removing element. 
Accordingly, no tag removal mediated by protease was required for the 
implementation of the discussed semisynthetic protocol. 
 
Expression 
The recombinant pETM13 plasmid coding the fragment 1-104 of CTPR3[1_3] variant 
fused to Mxe GyrA intein was utilized to transform bacterial cells, in order to express 
the corresponding fusion protein. The host cell chosen for fusion protein expression 
was the BL21-(DE3) strain of E. coli. The optimal expression conditions were 
selected by comparing different temperatures (22°C and 37°C), IPTG concentrations 
(0.3, 0.5 and 0.8 mM) and time of induction (5 h and overnight). Fusion protein 
accumulated in the soluble fraction of bacterial cells during the expression at 22°C, in 
all the conditions tested, while expression at 37°C caused the partial accumulation of 
the recombinant protein in inclusion bodies. The highest expression level was 
observed using 0.5 mM IPTG and performing the expression overnight at 22°C (Fig. 
20). No significant splicing in vivo of the intein was observed during expression, 
according to the data reported in literature assessing that, when an Asn residue is 
located in the protein-intein junction, no in vivo premature intein cleavage is observed 
[Southworth, M.W. et al. 1999]. 
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Figure 20 SDS-PAGE analysis of the fusion protein (CTPR3[1_3](fragment 1-104)-Mxe GyrA intein) 
(35.6 kDa) expressed in E. coli BL21-(DE3). The 15% polyacrylamide gel shows a molecular weight 
marker (lane 1), uninduced (lane 2) and induced (lane 3) cells samples. The SDS-PAGE analysis was 
performed using loading buffer without β-mercaptoethanol, in order to avoid splicing of the fusion 
protein. 
 
Purification procedure 
Fusion protein was purified from soluble fraction of bacterial cells by nickel affinity 
chromatography, exploiting the presence of the histidines tail situated at the C-
terminus of intein. All purification steps were performed at low temperature (4°C), in 
order to minimize intein splicing before the addition of thiols, which led to the release 
of the CTPR3 variant as a C-terminal carboxylic-acid, unable to react in NCL 
reaction. For the same reason, purification by nickel affinity chromatography was 
performed at lower pH value (pH 6.5) than that usually adopted for this kind of 
chromatography (pH 8.0). In fact, as described in the introductive chapter, intein 
splicing can be induced by temperature and pH as well as by thiols. Furthermore, we 
avoided the use of the tris(hydroxymethyl)aminomethane (Tris) buffer, which is 
usually preferred for this kind of affinity purification, because it has been 
demonstrated to react with the thioester protein forming a stable adduct and causing 
not negligible consequence on thioester protein final yields [Peroza, E.A & Freisinger, 
E. 2008]. Bacterial pellet from 1 L of culture was resuspended with ice-cold 50 mM 
phosphate buffer pH 6.5, 300 mM NaCl, 10 mM imidazole (buffer A), containing the 
proteases inhibitor PMSF to avoid fusion protein degradation. Cells suspension was 
sonicated and the lysate was centrifuged to recover the soluble fraction 
(supernatant). Cytosolic extract was then loaded onto a Ni2+-NTA agarose resin 
column pre-equilibrated in buffer A. Fusion protein was eluted using a buffer at high 
concentration of imidazole (50 mM phosphate buffer pH 6.5, 300 mM NaCl, 500 mM 
imidazole - buffer B) (Fig. 21). Elution of fusion protein was not performed applying a 
gradient of imidazole to the column, but in one step, to reduce the purification time 
and minimize the spontaneous cleavage of the intein. We obtained a yield of 100 mg 
of fusion protein from 1 L of culture. Once eluted, fusion protein was immediately 
incubated with a large excess of the splicing-inducing thiol MESNA (50 mM) at 4°C, 
under mild stirring, in order to obtain the C-terminal thioester derivatives of the N-
terminal fragment of CTPR3[1_3] variant. 
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Figure 21 SDS-PAGE analysis of the fusion protein CTPR3[1_3](fragment 1-104)-Mxe GyrA intein 
(35.6 kDa) after purification by affinity chromatography. The 15% polyacrylamide gel shows: molecular 
weight marker (lane 1); soluble fraction of induced E. coli BL21-(DE3) cells (lane 2), in the circle is 
indicated the fusion protein band; unbound proteins eluted from column (lane 3); column wash with 
buffer A (lane 4); fusion protein eluted with buffer B (lane 5). SDS-PAGE analysis was performed 
using a loading buffer without β-mercaptoethanol, in order to avoid splicing of the fusion protein. 
Intein splicing reaction was followed by time-course SDS-PAGE analysis (Fig. 22). 
After 6 days of incubation with thiols, ~50% of fusion protein underwent splicing. The 
observed rate of splicing is not in agreement with the data reported in literature 
[Southworth, M.W. et al. 1999], in which is stated that in presence of an Asn residue 
at the protein-intein splicing junction, an almost complete cleavage of the fusion 
protein is observed after overnight incubation with a thiol at 23°C. Probably, the lower 
temperature at which we performed the splicing (4°C) contributes to slowing down 
the splicing reaction rate. After 15 days of incubation with thiols, the percentage of 
cleaved protein is similar to that observed after 6 days. This observation suggests 
that, probably, the remaining part of the fusion protein failed to cleave because of 
misfolding or aggregation, justifying the slowing-down of the splicing reaction rate.  
 
 
 
Figure 22 Time-course analysis by SDS-PAGE of the splicing reaction. CTPR3[1_3](fragment 1-104)-
Mxe GyrA intein after 24 h, 48 h, 72 h and 6 days of incubation with 50 mM MESNA. 
Thioester group was stable in the experimental conditions of splicing reaction. In fact, 
the hydrolysis of thioester group was controlled adopting a slightly acidic pH value 
(6.5) and an excess of thiol reagent. After splicing, thioester protein was extensively 
dialyzed against 5 mM phosphate buffer pH 6.5 to remove salt and thiol excess, and 
then lyophilized. Then, C-terminal thioester protein fragment was reduced with TCEP 
and purified from spliced intein and unspliced fusion protein by reverse-phase HPLC. 
The thioester protein was obtained in a good purity (Fig. 23A). The identity of the 
thioester protein was verified by ESI mass spectrometry and found in agreement with 
expected value (Fig. 23B). The final yield of thioester protein was of about 15 mg 
from 1 L of culture. 
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Figure 23 LC-MS analysis of the thioester protein corresponding to the N-terminal fragment of 
CTPR3[1_3] after HPLC purification. A) Chromatographic profile revealed at 210 nm. B) Mass 
spectrum of the chromatographic peak at 19.46 min. Experimental mass (12319.8 Da) is in agreement 
with the theoretical one (12319.0 Da). C) Absorption spectrum of the chromatographic peak at     
19.46 min. 
 
First labeling reaction 
The thioester fragment 1-104 of CTPR3[1_3] was site-specifically labeled on the 
single Cys residue (position 36) with the maleimide derivative of the first molecular 
probe (acceptor fluorophore ATTO 647N). As ATTO 647N-maleimide is reported to 
react at pH value comprised between 7.0 and 7.5, we performed the labeling reaction 
at pH 7.2 in aqueous buffer (20 mM phosphate buffer), using a mild excess of 
fluorophore (two-fold molar excess). Reaction was carried out on the dark and at 
4°C, as we found ATTO 647N fluorophore significantly thermo unstable, losing its 
spectroscopic properties at room temperature. No reducing agent was used as, even 
if many protocols for Cys side chain labeling with maleimide derivative compounds 
recommend the use of the non-thiolic reducing agent TCEP, we observed that TCEP 
reacted with the maleimide moiety, preventing Cys labeling. This observation was 
also supported by previous works reported in literature [Shafer, D. E. et al. 2000; 
Tyagarajan, K. et al. 2003]. The labeling reaction was checked by LC-MS analysis 
and occurred with yield >90% within 2 h. As shown in the HPLC profile reported in 
Fig. 24, labeled thioester protein elutes as double peak, because ATTO 647N 
fluorophore is supplied as mixture of two isomers with identical absorption and 
emission properties. Mass value obtained from the deconvolution of the m/z signals 
obtained for the labeled protein showed an increment of 768 Da (Fig. 24B) respect to 
the thioester protein mass, consistent with the addition of a molecule of ATTO 647N-
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maleimide. The absorption spectrum of the protein peak shows the peculiar 
absorption features of the fluorophore ATTO 647N (Fig. 24C).  
 
 
Figure 24 LC-MS analysis of the labeling reaction of the thioester protein with ATTO 647N-maleimide. 
A) Chromatographic profile revealed at 210 nm. B) Mass spectrum of the chromatographic peaks at 
28.67 min and 28.93 min. Experimental mass (13090.0 Da) is in agreement with the theoretical one 
(13087.0 Da). C) Absorption spectrum of the chromatographic peaks at 28.67 min and 28.93 min.  
To prevent unspecific labeling on multiple sites, exceeding fluorophore was 
quenched by the addition of the thiol MESNA and then removed by dialysis against 
20 mM phosphate buffer pH 7.2. Dialysis was a pivotal step for the success of the 
subsequent chemical ligation reaction, because contributed to restore a pH value 
around the neutrality at which NCL occurs.  
 
Native Chemical Ligation with Cys-peptide 
The labeled thioester protein, corresponding to the fragment 1-104 of CTPR3[1_3] 
variant, was reacted with a synthetic peptide corresponding to the remaining portion 
of CTPR3[1_3] construct (protein fragment 105-120) (Fig. 25). The peptide, 
containing a Cys residue as N-terminal amino acid, was synthesized by Fmoc 
chemistry (see Experimental Section). 
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Figure 25 LC-MS analysis of the synthetic peptide corresponding to the C-terminal fragment of 
CTPR3[1_3] protein variant (amino acids 105-120). The Figure shows the chromatographic profile 
revealed at 210 nm. The insert shows mass spectrum of the chromatographic peak at 9.83 min. 
Experimental mass (1687.6 Da) is in agreement with the theoretical one (1687.8 Da). 
The experimental conditions for the NCL reaction were screened by comparing the 
yield of full-length protein obtained using different peptide molar excess (2, 5 and 10 
fold), thioester protein concentration (0.25 mM, 0.5 mM and 1 mM), pH values (7.2, 
7.5 and 7.8) and temperature (room temperature and 4°C), always in denaturing 
conditions. Moreover, in order to speed up the reaction, we also evaluated the effects 
of adding a thiol (MESNA) and a reducing agent (TCEP) to the reaction mixture. The 
best yield of full-length protein was obtained performing NCL at pH 7.5 in 100 mM 
phosphate buffer, 4 M GdnHCl,1 mM EDTA, 50 mM MESNA and 15 mM TCEP, and 
employing a ten-fold molar excess of peptide. NCL reaction was performed at 4°C to 
avoid fluorophore damage. The ligation reaction was checked by LC-MS and allowed 
to proceed until the disappearance of the thioester protein peak (~4 days at 4°C). In 
these conditions, ~70% of the thioester protein reacted with the peptide affording the 
full-length protein (Fig. 26). The remaining portion of thioester protein underwent 
hydrolysis, becoming unable to react with the peptide. After NCL with the Cys-
peptide, reaction mixture was dialyzed and lyophilized. Protein was then incubated 
with TCEP to reduce Cys residue in position 105, purified to homogeneity by reverse-
phase HPLC and lyophilized. 
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Figure 26 LC-MS analysis of the acceptor labeled CTPR3[1_3] protein obtained from NCL reaction. A) 
Chromatographic profile revealed at 210 nm. B) Mass spectrum of the chromatographic peaks at 
23.67 min and 23.98 min corresponding to the full-length CTPR3[1_3] protein labeled with ATTO 
647N-maleimide. Experimental mass (14637.0 Da) is in agreement with the theoretical one (14634.8 
Da). C) Absorption spectrum of the chromatographic peaks eluted at 23.67 min and 23.98 min.  
 
Second labeling reaction 
Mono-labeled CTPR3[1_3] protein variant was resuspended in phosphate buffer 20 
mM pH 7.2 and subjected to the second labeling reaction, performed with the donor 
dye ATTO 488-maleimide. Labeling reaction was carried out in the same 
experimental conditions adopted for the first labeling and, as verified by LC-MS 
analysis, it was completed within 2 h at 4°C. Deconvolution of the ESI spectrum gave 
a mass increment of 712 Da (Fig. 27B), as expected from the addition of a molecule 
of ATTO 488-maleimide. Absorption spectrum (Fig. 27C) revealed the appearance of 
an additional maximum, according to the ATTO 488 spectroscopic properties. After 
reaction occurred, to avoid multiple and unspecific labeling, exceeding fluorophore 
ATTO 488 was quenched with MESNA, the protein was dialyzed and lyophilized. 
Finally, doubly-labeled protein was reduced with TCEP, purified by reverse-phase 
HPLC and lyophilized (Fig. 27). 
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Figure 27 LC-MS analysis of the doubly-labeled CTPR3[1_3] variant. A) Chromatographic profile 
revealed by registering absorbance at 210 nm. B) Mass spectrum of the chromatographic peak at 
18.56 min. Experimental mass of the species (15344.7 Da) is in agreement with the theoretical one 
(15346.8 Da). C) Absorption spectrum of the chromatographic peak eluted at 18.56 min. 
67 
 
CTPR3[1_C], CTPR3[2_C] and CTPR3[N_C] variants preparation 
Doubly-labeled CTPR3[1_C], CTPR3[2_C] and CTPR3[N_C] constructs 
(schematically shown in Fig. 17C, #2, #3 and #4) were synthesized through the 
approach denoted as strategy B in Fig. 16. Due to the similarity of the procedures 
employed, the preparation of these three constructs will be discussed simultaneously 
in the following paragraphs. 
 
CTPR3[1_C], CTPR3[2_C] and CTPR3[N_C] variants design 
 
CTPR3[N_C], CTPR3[1_C] and CTPR3[2_C] variants share the position of the 
second probe, located at C-terminus of the protein, while the first probe is located in 
progressively more internal protein regions, going from the N-terminus to the central 
repeat. The sites of labeling in these three variants were selected basing on the 
same guidelines adopted for the CTPR3[1_3] variant design. Therefore, even in 
these constructs labeling on internal regions is performed on the Asn residue of the 
loops showing the less global propensity value for that position, avoiding protein 
structure perturbation. Labeling at N- or C- terminal regions is performed, instead, on 
residues inserted as extra-sequence amino acids, avoiding the introduction of 
mutations into the N-Cap and the C-terminal solvating extra-helix, which are known to 
be key elements of the CTPR protein stability [Main, E.R.G. et al. 2003]. Thus, in 
CTPR3[1_C] variant (Fig. 17C, #2) the first probe is located in position 36, on the 
more convenient Asn residue within the loop of the first repeat, while the second 
probe is placed at C-terminus (position 121). CTPR3[2_C] construct (Fig. 17C, #3) 
harbors the first probe in position 70, within the loop region of the second repeat, 
while second probe is placed at C-terminus, in position 121. CTPR3[N_C] (Fig. 17C, 
#4) bears the first fluorophores at N- terminus (position -1), while the second at the 
C-terminus (position 121).  
 
Cloning procedure 
The cloning strategy adopted for the preparation of CTPR3[1_C], CTPR3[2_C] and 
CTPR3[N_C] constructs is schematized in Fig. 28.  
For CTPR3[1_C] variant preparation, the gene coding the full CTPR3 protein (amino 
acids 1-120) and containing the mutation Asn36Cys (site of first labeling) was 
amplified from pProEXHTa-ctpr3(Asn36Cys) plasmid, whose production by cassette-
mutagenesis has been previously described in the section dedicated to CTPR3[1_3]. 
Instead, for CTPR3[2_C] variant preparation, in which the first label should be placed 
in position 70, the plasmid pProEXHTa-ctpr3 was newly mutagenized in order to 
introduce the mutation Asn70Cys, which is located in the second repeat of the 
protein. The same mutagenic approach used for the introduction of the mutation 
Asn36Cys was adopted, performing cassette-mutagenesis on the pProEXHTa-ctpr3 
plasmid. In this case, the plasmid was digested with SacI and HindIII restriction 
enzymes. The excised cassette was mutagenized by PCR, newly digested with SacI 
and HindIII and subcloned into pProEXHTa-ctpr3. The mutagenic plasmid obtained 
(pProEXHTa-ctpr3(Asn70Cys)) was used as template in a PCR reaction to amplify 
the gene coding CTPR3 including the mutation Asn70Cys (amino acids 1-120). 
Finally, for the preparation of the variant CTPR3[N_C], the gene coding full CTPR3 
protein with an N-terminal extra Cys was obtained through a PCR reaction performed 
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on the wild-type pProEXHTa-ctpr3 plasmid, using a mutagenic forward primer 
containing an extra Cys codon.  
As well as previously described for CTPR3[1_3], the genes coding CTPR3[1_C], 
CTPR3[2_C] and CTPR3[N_C] variants were amplified from their respective 
templates using forward primers adding NcoI restriction site and reverse primers 
generating a region of overlap with Mxe GyrA intein coding gene. Mxe GyrA intein 
gene was amplified from pTXB1 plasmid using forward primers generating a region of 
complementarity with the 3‟ end of the genes coding the CTPR3 variants. Then, the 
genes were fused by Overlapping Extension PCR reaction (Fig. 29). Each chimeric 
gene was digested with NcoI and EcoRI restriction enzymes and cloned into the 
pETM13 vector, which allowed the expression of C-terminal His6 tagged fusion 
proteins. All recombinant plasmids were verified by sequencing and used to 
transform bacterial cells for the expression of the fusion proteins. 
 
Figure 28 Preparation of the fusion genes coding CTPR3[1_C]-Mxe GyrA, CTPR3[2_C]-Mxe GyrA 
and CTPR3[N_C]-Mxe GyrA and cloning into pETM13. The gene coding CTPR3[1_C], CTPR3[2_C] 
and CTPR3[N_C] were obtained through PCR reaction carried out respectively on pProEXHTa-
ctpr3(Asn36Cys), pProEXHTa-ctpr3(Asn70Cys) and wild-type pProEXHTa-ctpr3. Construction of the 
chimeric genes was then performed by Overlapping Extension PCR, exploiting the complementary 
region introduced into the two components of the fusion gene. Genes were finally cloned in pETM13 
vector between NcoI and HindIII restriction sites. 
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Figure 29 Analysis by agarose gel electrophoresis of: A) genes coding CTPR3[1_C] (lane 1), 
CTPR3[2_C] (lane 5), CTPR3[N_C] (lane 7) and Mxe GyrA intein (lane 8) obtained from PCR 
reactions performed respectively on pProEXHTa-ctpr3(Asn36Cys), pProEXHTa-ctpr3(Asn70Cys), 
pProEXHTa-ctpr3 wild-type and pTXB1; in each gel is also loaded a molecular weight DNA marker 
(ladder 100 bp) (lane 1, 4, 6, 9). B) Overlapping Extension PCR reactions between CTPR3[1_C] and 
Mxe GyrA intein (lane 2), CTPR3[2_C] and Mxe GyrA intein (lane 4), CTPR3[N_C] and Mxe GyrA 
intein (lane 6). The black circles highlight bands corresponding to the fusion genes. Ladder 100 bp is 
also loaded in each agarose gel (lane 1, 3, 6). 
 
Expression 
Expression of the fusion proteins CTPR3[1_C]-Mxe GyrA intein, CTPR3[2_C]-Mxe 
GyrA intein and CTPR3[N_C]-Mxe GyrA intein was performed in the same 
experimental conditions selected for the expression of CTPR3[1_3](fragment 1-104)-
Mxe GyrA intein (expression was inducted with 0.5 mM IPTG and performed at 22°C 
overnight). All fusion proteins accumulate in the soluble fraction of E. coli BL21-(DE3) 
bacterial cells and exhibit comparable expression levels (Fig. 30). Even in these 
cases, no splicing in vivo of the intein was observed during the expression, as a Gly 
residue is located at the splicing junction in all the three variants and such amino acid 
is not included among the amino acids causing in vivo premature cleavage of the 
intein [Southworth, M.W. et al. 1999]. 
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Figure 30 SDS-PAGE analysis of fusion proteins A) CTPR3[1_C]-Mxe GyrA intein (37.3 kDa), B) 
CTPR3[2_C]-Mxe GyrA intein (37.3 kDa) and C) CTPR3[N_C]-Mxe GyrA intein (37.5 kDa) expressed 
in E. coli BL21-(DE3). Each 15% polyacrylamide gel shows uninduced (lane 2) and induced (lane 3) 
cells samples. In each gel is also loaded a molecular weight marker (lane 1). All the SDS-PAGE 
analyses were performed using loading buffer without β-mercaptoethanol, to avoid splicing of the 
fusion proteins.  
 
Purification 
Fusion proteins purification was accomplished as described for CTPR3[1_3] variant. 
Therefore, all the His6-tagged fusion proteins were isolated by affinity 
chromatography, following the same procedure previously discussed (Fig. 31).  
 
 
Figure 31 SDS-PAGE analysis of fusion protein CTPR3[N_C]-Mxe GyrA intein (37.5 kDa) after 
purification by affinity chromatography. Molecular weight marker (lane 1); soluble fraction of induced E. 
coli BL21-(DE3) cells (lane 2), in the black circle is highlighted the fusion protein band; unbound 
proteins eluted from column (lane 3); column wash with buffer A (lane 4); fusion protein eluted with 
buffer B (lane 5). Similar purification profiles were obtained for CTPR3[1_C]-Mxe GyrA intein and 
CTPR3[2_C]-Mxe GyrA intein fusion proteins purification (data not shown). SDS-PAGE analysis was 
performed using a loading buffer without β-mercaptoethanol, in order to avoid splicing of the fusion 
protein. 
After isolation of the fusion proteins, C-terminal thioester derivative of each CTPR3 
variant was obtained through intein thiolysis, reacting the intein-tagged proteins 
eluted from the resin with the thiol MESNA. Intein splicing was accomplished in the 
same experimental conditions adopted for CTPR3[1_3] variant. However, in this case 
an almost complete cleavage of the intein was observed after 6 days of incubation 
with 50 mM MESNA at 4°C, as observed following intein splicing reaction for the 
fusion proteins CTPR3[N_C]-Mxe GyrA intein by time-course SDS-PAGE analysis 
(Fig. 32). Even if Gly residue in the splicing junction is reported to promote splicing 
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reaction with similar efficiency than Asn, in this case the splicing proceeded faster 
than in CTPR3[1_3]. In fact, in the same conditions and after the same incubation 
time, only 50% of fusion protein CTPR3[1_3](fragment 1-104)-Mxe Gyr A intein was 
observed undergoing splicing, because of the aggregation or misfolding of part of the 
fusion protein (compare Fig. 22 with Fig. 31). In this case, instead, all the preparation 
of fusion protein was well folded and underwent splicing, so that, globally, splicing 
reaction appeared to proceed with higher rate.  
 
 
Figure 32 Time-course analysis by SDS-PAGE of the splicing reaction. CTPR3[N_C]-Mxe GyrA intein 
after 24 h, 48 h and 6 days of incubation with MESNA 50 mM. Similar results were observed for the 
other two fusion proteins, CTPR3[1_C]- Mxe GyrA intein and CTPR3[2_C]-Mxe GyrA intein, harboring 
a Gly residue at the splicing junction. 
After splicing reaction occurred, reaction mixture was dialyzed against 5 mM 
phosphate buffer pH 6.5, lyophilized and purified by reverse-phase HPLC to isolate 
thioester proteins from intein and residual unspliced fusion protein. The thioester 
proteins were obtained in good purity (Fig. 33, 34 and 35). The identity of the 
thioester proteins was verified by ESI mass spectrometry and found in agreement 
with theoretical values (Fig. 33B, 34B and 35B). The final yield of thioester proteins 
was, on average, of 20 mg from 1 L of culture. 
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Figure 33 LC-MS analysis of the thioester protein CTPR3[1_C] after HPLC purification. A) 
chromatographic profile revealed at 210 nm. B) Mass spectrum of the chromatographic peak revealed 
at 23.58 min. Experimental mass (13999.5 Da) is in agreement with the theoretical one (14000.9 Da). 
C) Absorption spectrum of the of the chromatographic peak at 23.58 min. 
 
 
Figure 34 LC-MS analysis of the thioester protein CTPR3[2_C] after HPLC purification. A) 
chromatographic profile revealed at 210 nm. B) Mass spectrum of the chromatographic peak revealed 
at 18.73 min. Experimental mass (13999.4 Da) is in agreement with the theoretical one (14000.9 Da). 
C) Absorption spectrum of the of the chromatographic peak at 18.73 min. 
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Figure 35 LC-MS analysis of the thioester protein CTPR3[N_C] after HPLC purification. A) 
chromatographic profile revealed at 210 nm. B) Mass spectrum of the chromatographic peak revealed 
at 23.07 min. Experimental mass (14166.8 Da) is in agreement with the theoretical one (14172.18 Da). 
C) Absorption spectrum of the of the chromatographic peak at 23.07 min. 
 
First labeling reaction 
Thioester derivatives of CTPR3[1_C], CTPR3[2_C] and CTPR3[N_C] proteins were 
site-specifically labeled on their Cys residue (respectively located in position 36, 70 
and N-terminal) with the acceptor fluorophore ATTO 647N-maleimide. The reaction 
was performed as previously described for the labeling of the fragment 1-104 of 
CTPR3[1_3], in 20 mM phosphate buffer pH 7.2, at 4°C on the dark, using a two-fold 
molar excess of ATTO 647N-maleimide, and occurred with a similar yield (above 
90% within 2 h) (Fig. 36). Exceeding fluorophore was quenched with the thiol MESNA 
and then reaction mixture was extensively dialyzed against 20 mM phosphate buffer 
pH 7.2. This step of dialysis ensured restoring of a pH value of 7.2, at which 
subsequent NCL with L-Cysteine was performed. 
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Figure 36 LC-MS analysis of the labeling reaction of the thioester protein CTPR3[N_C] with ATTO 
647N-maleimide. A) Chromatographic profile revealed at 210 nm. B) Mass spectrum of the 
chromatographic peaks at 27.27 min and 27.58 min. Experimental mass (14934.8 Da) is in agreement 
with the theoretical one (14940.2 Da). C) Absorption spectrum of the thioester protein peaks at 27.27 
and 27.58 min. Similar data were obtained for thioester protein CTPR3[1_C] and CTPR3[2_C] (data 
not shown). 
 
Native Chemical Ligation with L-Cys 
Mono-labeled thioester proteins were reacted with L-Cys through NCL, in order to 
introduce an additional Cys residue at C-terminal position. The best NCL conditions 
were selected by comparing reaction yield at different pH value (in the range 7.0-8.0), 
temperature (room temperature and 4°C), L-Cys excess (in the range 10-100 fold) 
and protein concentration (in the range 0.1-1.0 mM) in presence or absence of a 
denaturing agent (GdnHCl). NCL with L-Cys occurred with high yield (above 90%) in 
all the conditions tested. We decided to perform the NCL reaction in native 
conditions, using an aqueous buffer at pH 7.2 and a 20 fold molar excess of L-Cys. 
Reaction went to completion after an incubation overnight at 4°C, under stirring (Fig. 
37, 38, 39). Ligation reaction was performed at 4°C to preserve ATTO 647N integrity. 
After NCL occurred, reaction mixtures were lyophilized and purified by reverse-phase 
HPLC. Before performing the chromatography, samples were incubated with TCEP 
to reduce C-terminal Cys residue. 
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Figure 37 LC-MS analysis of CTPR3[1_C] variant obtained from NCL with L-Cys. A) Chromatographic 
profile revealed by at 210 nm. B) Mass spectrum of the chromatographic peaks at 27.36 min and 
27.57 min. Experimental mass (14749.4 Da) is in agreement with the theoretical one (14748.9 Da). C) 
Absorption spectrum of the protein peaks at 23.36 min and 27.57 min. Sample was incubated with 
TCEP before LC-MS analysis to reduce C-terminal Cys. 
 
Figure 38 LC-MS analysis of CTPR3[2_C] variant obtained from NCL with L-Cys. A) Chromatographic 
profile revealed by at 210 nm. B) Mass spectrum of the chromatographic peaks at 27.36 min and 
27.57 min. Experimental mass (14741.9 Da) is in agreement with the theoretical one (14748.9 Da). C) 
Absorption spectrum of the protein peaks at 23.0 min. Sample was incubated with TCEP before LC-
MS analysis to reduce C-terminal Cys. 
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Figure 39 LC-MS analysis of CTPR3[N_C] variant obtained from NCL with L-Cys. A) 
Chromatographic profile revealed by at 210 nm. B) Mass spectrum of the chromatographic peaks at 
27.53 min and 27.84 min. Experimental mass (14916.2 Da) is in agreement with the theoretical one 
(14920.2 Da). C) Absorption spectrum of the protein peaks at 23.0 min. Sample was incubated with 
TCEP before LC-MS analysis to reduce C-terminal Cys. 
 
Second labeling reaction 
All the obtained mono-labeled variants were resuspended in 20 mM phosphate buffer 
pH 7.2 and subjected to the second labeling reaction, performed with the donor dye 
ATTO 488-maleimide, as also described for CTPR3[1_3]. Doubly-labeled proteins 
were purified by reverse-phase HPLC and lyophilized (Fig. 40, 41 and 42). The minor 
peaks in the chromatographic profiles reported in Fig. 40, 41 and 42 (19.03 min, 
18.68 min, 17 min respectively) show the m/z signal of the doubly-labeled species but 
their absorption spectra do not show the absorption maximum at 644 nm of ATTO 
647N but only the one of ATTO 488 at 501 nm. This observation indicates that in an 
aliquot of sample ATTO 647N fluorophore is damaged. 
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Figure 40 LC-MS analysis of the doubly-labeled CTPR3[1_C]. A) Chromatographic profile revealed at 
210 nm. B) Mass spectrum of the protein peaks at 23.12 min and 23.36 min. Experimental mass 
(15455.9 Da) is in agreement with the theoretical one (15460.9 Da). C) Absorption spectrum of the 
chromatographic peaks at 23.12 min and 23.36 min. 
 
Figure 41 LC-MS analysis of the doubly-labeled CTPR3[2_C]. A) Chromatographic profile revealed at 
210 nm. B) Mass spectrum of the protein peaks at 22.92 min and 23.19 min. Experimental mass 
(15455.8 Da) is in agreement with the theoretical one (15460.9 Da). C) Absorption spectrum of the 
chromatographic peaks at eluted at 23.12 min and 23.36 min. 
78 
 
 
Figure 42 LC-MS analysis of the doubly-labeled CTPR3[N_C]. A) Chromatographic profile revealed at 
210 nm. B) Mass spectrum of the protein peaks at 21025 min and 21.50 min. Experimental mass 
(15623.2 Da) is in agreement with the theoretical one (15632.2 Da Da). C) Absorption spectrum of the 
chromatographic peaks at eluted at 23.12 min and 23.36 min. 
 
Mono-labeled and unlabeled control constructs preparation 
Control constructs harboring only the donor or the acceptor fluorophore or none of 
them were also prepared using the same approach adopted for the semisynthesis of 
the doubly-labeled species. Such control constructs were needed to carry out a 
complete spectroscopic characterization of the doubly-labeled species, in order to 
assess the effects of the introduction of each fluorophore and of the mutations on the 
stability of CTPR3 and to perform fluorescence anisotropy studies. All the doubly-
labeled, mono-labeled and unlabeled constructs prepared are listed in Table IV. 
Unlabeled proteins containing the two Cys residues in the same position as the 
doubly-labeled proteins (Table IV #2-4) were obtained carrying out NCL reactions 
between unlabeled thioester moieties and L-Cys or Cys-peptide, as described for the 
preparation of the labeled analogs. Unlabeled CTPR3[N_C] protein was not prepared 
because this variant does not contain internal mutations but only insertions at N- and 
C-termini, and we assume it to retain the same stability of the wild-type protein (Table 
IV #1). Mono-labeled proteins, containing only the first fluorophore of FRET pair 
ATTO 647N in position N-terminal, 36 or 70 and the second Cys free (Table IV, #6-
9), were prepared concomitantly with the preparation of the doubly-labeled variants. 
The control construct containing only the second fluorophore of the pair, ATTO 488, 
at C-terminal position (Table IV #5) was prepared expressing the wild-type CTPR3 
protein as fusion construct with Mxe GyrA intein; thioester CTPR3, which does not 
contain Cys residues, was reacted in NCL reaction with L-Cys, adding a single Cys 
residue at the C-terminus. Cys was labeled with ATTO 488 similarly as before 
described. 
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Spectroscopic characterization of CTPR3 protein variants 
It was showed [Kajander et al. 2005; Main, E.R.G. et al. 2005; Hagay, T. & Levy, Y. 
2008; Javadi, Y. & Main, E.R.G. 2009] that CTPR3 unfolding follows the Ising model 
and proceeds from the external helices towards the protein interior [Cortajarena, A.L. 
et al. 2008]. This behavior could be verified using the doubly-labeled CTPR3 variants 
prepared monitoring the unfolding process by CD and FRET. These studies were 
performed in collaboration with Prof. Lynne Regan and Dr. Aitziber Lopez 
Cortajarena from the Department of Molecular Biophysics & Biochemistry of Yale 
University (New Haven, CT-USA). 
 
CD characterization 
In order to verify if the semisynthetic CTPR3 variants retained the typical CTPR3 
protein folding despite the presence of mutations and fluorophores, all the prepared 
constructs (doubly-labeled proteins as well as the mono-labeled and unlabeled 
control constructs, Table IV) were analyzed by far-UV CD spectroscopy. CD spectra, 
recorded in the 190-260 nm region, clearly demonstrate that all the variants exhibit 
an overall helical structure, indicating that the introduction of mutations and 
fluorophores into CTPR3 does not lead to a substantial disruption of the native 
protein fold (Fig. 43). 
 
Figure 43 Far-UV CD spectrum of doubly-labeled CTPR3[1_C]. Similar spectra were observed for all 
the other variants. 
 
Next, we verified if the mutations and the labels introduced into CTPR3 affect protein 
global stability. This control is needed to compare the results obtained for each 
construct from the folding studies. To this aim, we carried out heat-denaturation 
experiments on all the doubly-labeled, mono-labeled and unlabeled CTPR3 variants. 
The thermal unfolding process of the CTPR3 variants was followed by CD, 
monitoring ellipticity at 222 nm, a signature of the helical structure, in the temperature 
range 10-94°C. Protein unfolded fraction at each temperature was estimated 
assigning 0% and 100% values to the ellipticity recorded respectively at 10°C and 
94°C. Table IV shows the Tm values (melting temperature, the temperature at which 
the protein unfolded fraction is 50%) estimated for the CTPR3 variants.  
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Table IV List of all the CTPR3 variants analyzed by CD. All the Unlabeled constructs are denoted with 
UL. The mono-labeled constructs carrying only the acceptor ATTO 647N or the donor ATTO 488 are 
marked with A (=Acceptor) or D (=Donor) respectively. Doubly-labeled proteins are indicated with AD 
(Acceptor and Donor). The values of the melting temperatures (Tm) are reported in last column.  
Fig. 44 shows the denaturation curves of the unlabeled species compared with that 
observed for CTPR3 wild-type. Fig. 45, 46, 47 and 48 show the denaturation curves 
respectively obtained for doubly-labeled protein CTPR3[N_C], CTPR3[1_C], 
CTPR3[2_C] and CTPR3[1_3] in comparison with their mono-labeled and unlabeled 
counterparts.  
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Figure 44 Thermal denaturation curves of CTPR3 unlabeled control constructs (CTPR3 UL) and 
CTPR3 wild-type (CTPR3 WT). 
 
Figure 45 Thermal denaturation curves of doubly-labeled CTPR3[N_C] (CTPR3[N_C]-AD), mono-
labeled constructs (CTPR3[N_C]-A and CTPR3-D) and CTPR3 wild-type (CTPR3 WT). 
 
Figure 46 Thermal denaturation curves of doubly-labeled CTPR3[1_C] (CTPR3[1_C]-AD), mono-
labeled constructs (CTPR3[1_C]-A and CTPR3-D) and unlabeled variant (CTPR3[1_C] UL). 
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Figure 47 Thermal denaturation curves of doubly-labeled CTPR3[2_C] (CTPR3[2_C]-AD), mono-
labeled constructs (CTPR3[2_C]-A and CTPR3-D) and unlabeled variant (CTPR3[2_C] UL). 
 
 
 
 
Figure 48 Thermal denaturation curves of doubly-labeled CTPR3[1_3] (CTPR3[1_3]-AD), acceptor 
mono-labeled construct (CTPR3[1_3]-A) and unlabeled variant (CTPR3[1_3] UL). 
All the unlabeled CTPR3 variants (Table IV #2, 3 and 4, Fig. 44), which harbor the 
two mutations but no fluorophores, exhibit a thermal stability (Tm=78.5°C) 
comparable with CTPR3 wild-type (Tm=80°C), demonstrating that the mutations 
introduced into CTPR3 sequence do not affect the protein stability. Similarly, 
CTPR3[N_C]-A (Table IV #5), carrying only the acceptor label at N-terminus, and 
CTPR3-D (Table IV #6), harboring only the donor fluorophore at C-terminal position, 
exhibit Tm values of 77°C and 81°C, which are comparable to those estimated for the 
unlabeled and wild-type species. These data suggest that labeling on terminal 
regions does not affect the protein structural stability. On the contrary, CTPR3[1_3]-A 
(Table IV #7) and CTPR3[1_C]-A (Table IV #9), labeled only with the acceptor 
fluorophore in position 36, show Tm values slightly lower with respect to those 
estimated for the unlabeled mutant and the wild-type protein (69.5 and 71.5°C). 
These data demonstrate that, when placed inside the protein sequence instead than 
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on the terminal regions, fluorophores slightly destabilize the protein. However, 
CTPR3[2_C]-A (Table IV #8), which carries the fluorophore ATTO 647N in position 
70, shows a Tm value (75.1°C) higher than those observed for CTPR3[1_C]-A and 
CTPR3[1_3]-A. This observation could be justified considering that in CTPR3[2_C]-A 
the fluorophore is placed in the protein loop connecting the second and the third 
repeat, which is a more internal and hence higher stable region respect to the first 
loop. Thermal stability data obtained for the doubly-labeled species are in agreement 
with the results achieved for the mono-labeled or unlabeled control constructs. 
Doubly-labeled CTPR3[N_C]-AD (Table IV #10) exhibits a Tm of 76.0°C, showing 
only a slightly destabilization according to the presence of the two labels on the 
terminal regions. Similar results are obtained for CTPR3[2_C]-AD (Table IV #12) (Tm 
76.8°C). Contrariwise, Tm values estimated for doubly-labeled CTPR3[1_C]-AD 
(Table IV #11) and CTPR3[1_3]-AD (Table IV #13) are respectively 72.5°C and 
65.5°C, according to the presence of the acceptor dye within the first loop that we 
assessed to be a destabilizing factor. CTPR3[1_3] shows the lowest stability that 
could be attributed to the presence of both fluorophores inside the protein sequence.  
Globally, CD data suggest that neither the mutations nor the labels introduced into 
protein sequence affect considerably CTPR3 native fold, which is an essential 
conditions for the conduction of folding studies on the CTPR3 variants. However, 
mutations and labels slightly destabilize proteins. 
 
Fluorescence anisotropy measurements 
To assess whether the fluorophores are freely rotating when attached to the protein 
or, conversely, interactions occur between protein and dyes, we carried out 
fluorescence anisotropy experiments on the mono-labeled CTPR3 protein variants. 
The anisotropy of these constructs was compared to that exhibited by dyes in their 
free form. All the CTPR3 variants present similar anisotropy values, independently on 
the position of dyes, and moreover the values obtained suggest that the dyes are 
freely rotating when attached to the protein, ensuring that labels do not mediate 
protein aggregation (Table V). 
 
 
Table V Fluorescence anisotropy measurements on mono-labeled control constructs.  
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Ensemble-FRET studies on Doubly-labeled CTPR3 protein variants  
ATTO 488 and ATTO 647N were respectively selected as donor and acceptor dyes 
because they were predicted to be well suited for probing by FRET the transition from 
the native to the unfolded state in the doubly-labeled CTPR3 protein variants. In fact, 
the distances between fluorophores in the native state of the four doubly-labeled 
constructs are predicted to be 52 Å in CTPR3[N_C], 40.3 Å in CTPR3[1_C], 31.3 Å in 
CTPR3[2_C] and 28.4 Å in CTPR3[1_3] from CTPR3 x-ray structure. Such distance 
values are similar to the the R0 of ATTO 647N/488 pair (49 Å). R0 of a fluorophores 
pair is defined as the distance (R) at which FRET efficiency (E) is 0.5 and 
corresponds to the inflection point of the plot in Fig.49, which reports E for ATTO 
647N/488 in function of the distance (R) between the two dyes. Therefore, the 
increase of the distance between fluorophores occurring upon protein unfolding 
should result in appreciable variation of FRET efficiency (E) between the two dyes. 
 
Figure 49 FRET efficiency (E) dependence from distance (R) for ATTO 647N/488 fluorophores pair 
(R0 = 49 Å). 
We verified the ability of the selected pair, ATTO 647N and ATTO 488, to reveal 
global folding-unfolding transitions by FRET experiments. To this purpose, 
fluorescence spectra of the doubly-labeled CTPR3 variants were registered in the 
native (0 M GdnHCl) and chemically-unfolded state (4 M GdnHCl) (Fig. 50, 51, 52 
and 53).  
 
Figure 50 Emission spectra of doubly-labeled CTPR3[N_C] protein in native ([GdnHCl] = 0 M) 
(dashed line) and denaturing conditions ([GdnHCl] = 4 M) (solid line). The doubly-labeled construct 
under investigation is schematically represented on the right of the graph. 
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Figure 51 Emission spectra of doubly-labeled CTPR3[1_C] protein in native ([GdnHCl] = 0 M) (dashed 
line) and denaturing conditions ([GdnHCl] = 4 M) (solid line). The doubly-labeled construct under 
investigation is schematically represented on the right of the graph. 
 
 
Figure 52 Emission spectra of doubly-labeled CTPR3[2_C] protein in native ([GdnHCl] = 0 M) (dashed 
line) and denaturing conditions ([GdnHCl] = 4 M) (solid line). The doubly-labeled construct under 
investigation is schematically represented on the right of the graph. 
 
 
Figure 53 Emission spectra of doubly-labeled CTPR3[1_3] protein in native ([GdnHCl] = 0 M) (dashed 
line) and denaturing conditions ([GdnHCl] = 4 M) (solid line). The doubly-labeled construct under 
investigation is schematically represented on the right of the graph. 
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Unfolding was performed by chemical means because of the thermal instability of 
ATTO 647N dye. Doubly-labeled protein samples were excited at the donor 
maximum absorbance wavelength (503 nm) and the fluorescence emission spectra 
were recorded in the wavelength range 505 nm-700 nm, including both donor and 
acceptor emission maximum (523 nm and 669 nm respectively). Fluorescence 
spectra recorded for the four doubly-labeled variants of CTPR3 in native conditions 
display evidence of FRET, showing E values of 0.21 in the construct CTPR3[N_C] 
(Fig. 50), 0.40 in CTPR3[1_C] (Fig. 51), 0.67 in CTPR3[2_C] (Fig. 52) and 0.82 
CTPR3[1_3] (Fig. 53) (Table VI). As expected, in the native state the four doubly-
labeled proteins exhibit progressively higher values of FRET efficiency going from 
CTPR3[N_C] to CTPR3[1_C], CTPR3[2_C] and CTPR3[1_3] constructs, according to 
a progressive decrease of the distance between dyes. In particular, the donor 
fluorescence is quenched almost completely in CTPR3[1_3], indicating that the 
distance between donor and acceptor is well within the Förster distance of the FRET 
pair. The discrepancy between the distances calculated from the E values obtained 
for the proteins in the native state and the theoretical values (Table VI) could be 
explained considering that these latter values are estimated from CTPR3 x-ray 
structure considering the C -C  distance of the labeled amino acids. The distance 
increment due to the fluorophores was not taken into consideration. As expected, 
addition of a denaturant (GdnHCl) causes the donor fluorescence to increase, while 
acceptor fluorescence decreases, demonstrating that in all constructs FRET process 
is sensitive to changes in distance between the fluorophores going from the native to 
the unfolded state. A different result was observed in the fluorescence spectra of the 
denatured state of CTPR3[N_C] (Fig. 50). In fact, upon unfolding, we registered a 
decrease of the acceptor emission intensity fluorophore without a correlated increase 
of donor dye emission intensity. This unusual behavior could be due to the quenching 
of the donor dye mediated by the side-chain of neighboring residue, which is instead 
impeded by its restricted orientation in the native helical structure. When the native 
structure unwinds upon chemical denaturation, stereochemical restriction is relaxed 
and the quenching effect is more efficient. A similar observation was also reported by 
Ratner and coworkers (Ratner, V. et al. 2002). E values after denaturation fall down 
to 0.06 for CTPR3[N_C] (Fig. 50), 0.1 in CTPR3[1_C] (Fig. 51), 0.14 in CTPR3[2_C] 
(Fig. 52) and 0.19 CTPR3[1_3] (Fig. 53), according to the progressively shorter 
distance between dyes in the polypeptide chain (Table VI). 
 
 
Table VI FRET efficiency (E) and distance between fluorophores (R) predicted from CTPR3 x-ray 
structure and calculated from FRET experiments data. 
These data demonstrate the efficacy of the FRET pair employed in yielding 
information about changes in the distance between the donor and the acceptor dyes, 
opening the way to further folding studies by fluorescence spectroscopy approaches. 
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Chemical denaturation studies by CD and FRET 
According to the end-frying unfolding model followed by TPR proteins [Kajander et al. 
2005; Main, E.R.G. et al. 2005; Cortajarena, A.L. et al. 2008; Hagay, T. & Levy, Y. 
2008; Javadi, Y. & Main, E.R.G. 2009] the unfolding process starts with the 
unwinding of terminal regions and proceeds towards the middle of the protein. 
Therefore, we speculated that, monitoring unfolding process of the doubly-labeled 
constructs by CD and FRET, we should obtain different results for each variant. In 
fact, while CD monitors the total protein helical content revealing the unfolding 
process in its globality, FRET is sensible to local denaturation events. Consequently, 
we expected, comparing unfolding experiments by CD and FRET, to reveal 
differences in the unfolding transitions depending on the location of the two probes. 
For example, the unfolding transition by FRET for CTPR3[N_C], which carries the 
two fluorophores in the terminal regions, should precede that obtained by CD. On the 
contrary, the unfolding transition for CTPR3[1_3], which probes are placed in the 
central region, should appear before by CD and then by FRET. In fact, the distance 
between the two fluorophores is expected to change only at the end of the unfolding 
process, when the content of secondary structure is very low. Accordingly, 
CTPR3[1_C] and CTPR3[2_C] should exhibit an intermediate behavior. 
To verify our hypothesis, we carried out chemical denaturation experiments on the 
doubly-labeled variants monitoring the unfolding process simultaneously by CD and 
FRET and comparing the obtained plots (Fig. 54, 55, 56 and 57).  
Chemical denaturation was carried out by titration with GdnHCl within the 
concentration range 0 M – 5 M. CD and FRET spectra of the doubly-labeled protein 
samples were acquired at each denaturant concentration, respectively in the range 
190-260 nm and 505-700 nm. Protein unfolded fraction content at each chemical 
denaturant concentration was evaluated assigning 0% and 100% value to the 
ellipticity and to the donor/acceptor fluorescence intensities ratio recorded 
respectively in the native ([GdnHCl] 0 M) and unfolded state ([GdnHCl] 5 M). 
 
 
Figure 54 Chemical denaturation curves obtained for the doubly-labeled protein CTPR3[N_C] 
monitoring the unfolding process by CD and FRET. 
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Figure 55 Chemical denaturation curves obtained for the doubly-labeled protein CTPR3[1_C] 
monitoring the unfolding process by CD and FRET. 
 
 
Figure 56 Chemical denaturation curves obtained for the doubly-labeled protein CTPR3[2_C] 
monitoring the unfolding process by CD and FRET. 
 
 
Figure 57 Chemical denaturation curves obtained for the doubly-labeled protein CTPR3[1_3] 
monitoring the unfolding process by CD and FRET. 
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FRET unfolding curves obtained for the doubly-labeled CTPR3 variants overlap CD 
plots, except for CTPR3[1_3] whose CD plot does not seem to depict a cooperative 
process. The CD plot observed for CTPR3[1_3] could be ascribed to its instability, as 
previously demonstrated through thermal denaturation studies, so that the protein 
unfolds at lower GdnHCl concentration than the other variants. To obtain a better 
resolution of the CD and FRET unfolding plots, we decided to perform the same kind 
of experiments using a weaker denaturant, such as the urea. Besides allowing a 
better resolution of the denaturation curves, urea also is known to have less effect 
than GdnHCl on the refractive index and spectral properties of the dyes. Denaturation 
studies with urea were performed as described for experiments with GdnHCl, ranging 
urea concentration from 0 M to 8.25 M (Fig. 58, 59, 60, 61 and Table VII). 
 
Figure 58 Urea denaturation curves obtained for the doubly-labeled protein CTPR3[N_C] monitoring 
the unfolding process by CD and FRET.  
 
 
Figure 59 Urea denaturation curves obtained for the doubly-labeled protein CTPR3[1_C] monitoring 
the unfolding process by CD and FRET.  
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Figure 60 Urea denaturation curves obtained for the doubly-labeled protein CTPR3[2_C] monitoring 
the unfolding process by CD and FRET.  
 
Figure 61 Urea denaturation curves obtained for the doubly-labeled protein CTPR3[1_3] monitoring 
the unfolding process by CD and FRET.  
 
 
 
Table VII Urea concentration at the CD and FRET transition points for the doubly-labeled CTPR3 
proteins. 
In CTPR3[1_3], FRET unfolding curve followed CD unfolding curve (transition points 
were respectively registered at 6.25 M and 5.25 M [urea]) (Fig. 61 and Table VII). 
This observation is in agreement with the Ising model, by which CTPR proteins are 
predicted to unfold. In fact, in this construct the labels are placed on internal protein 
region, which unfolds later. In CTPR3[2_C], FRET and CD unfolding plots are 
overlapped (transition points respectively at 6.25 M and 6.5 M) (Fig. 60 and Table 
VII). This observation is in agreement with an increased distance between the 
fluorophores, respect to the construct CTPR3[1_3], one of which is placed in the C-
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terminal region which is a region more prone to unfold. Strange observations come 
from CTPR3[N_C] and CTPR3[1_C] unfolding plots (Fig 58 and 59). On the basis of 
what observed for CTPR3[1_3] and CTPR3[2_C], in the constructs CTPR3[N_C] and 
CTPR3[1_C], in which the distance between the two labels is higher and the labels 
are positioned in more external regions, the transition monitored by FRET is 
expected to precede the CD transition. Interestingly, the results show that unfolding 
transition of CTPR3 variants CTPR3[N_C] and CTPR3[1_C] reported by FRET 
occurs at higher denaturant concentrations than that measured by CD (Table VII). 
These data are indicative of a deviation from a simple scenario in which FRET 
transitions are only function of helical structure loss. Probably, additional phenomena 
cause a deviation of the unfolding transition plot to higher denaturant concentrations. 
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CONCLUSIONS 
 
The development of methods for the chemical modification of proteins provides a 
means by which to characterize and modulate protein structure and function. 
Different approaches, based on the use of both chemistry and/or molecular biology, 
have been proposed to prepare proteins specifically modified at multiple sites. 
However, most of the these technologies are limited by high experimental efforts, low 
yields, low adaptability to different targets and different kinds of modifications. This 
PhD thesis reports a useful and easy-to-perform protocol for the synthesis and 
modification of proteins which overcomes the major limits of the precedent strategies 
for protein labeling. The semi-synthetic strategy proposed, based on the use of EPL, 
is generally applicable for the preparation of proteins in which a combination of two 
different labels is incorporated at any desired position, but could also be adapted to 
the introduction of more than two probes. The effectiveness of the designed 
semisynthetic strategy has been assessed through the preparation of four variants of 
CTPR3, a consensus tetratrico peptide repeat protein, labeled with a fluorophores 
pair and useful for folding studies by fluorescence spectroscopy approaches. The 
obtained fluorescent variants have been characterized through biophysical studies. 
The intriguing results of these preliminary structural analysis open the way to further 
folding studies by single-molecule spectroscopic approaches, such as sm-FRET and 
FCS, aimed to gain deeper insights into repeat protein folding mechanism and 
dynamics.  
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